microRNA information: hsa-miR-335-5p
| Section | ID | link |
|---|---|---|
| Mature name: | hsa-miR-335-5p | miRbase |
| Accession: | MIMAT0000765 | miRbase |
| Precursor name: | hsa-mir-335 | miRbase |
| Precursor accession: | MI0000816 | miRbase |
| Symbol: | MIR335 | HGNC |
| RefSeq ID: | NR_029899 | GenBank |
| Sequence: | UCAAGAGCAAUAACGAAAAAUGU |
Reported expression in cancers: hsa-miR-335-5p
| miRNA | cancer | regulation | reporting | PUBMED | method |
|---|---|---|---|---|---|
| hsa-miR-335-5p | acute myeloid leukemia | upregulation | "This paper evaluated the association between micro ......" | 25646775 | RNA-Seq |
| hsa-miR-335-5p | bladder cancer | deregulation | "In GBC miRNAs with tumor suppressor activity miR-1 ......" | 26855538 | |
| hsa-miR-335-5p | breast cancer | downregulation | "Expression status of let 7a and miR 335 among brea ......" | 24942235 | |
| hsa-miR-335-5p | breast cancer | downregulation | "In this study we showed that miR-335 is downregula ......" | 25323813 | |
| hsa-miR-335-5p | breast cancer | downregulation | "A previous study has shown that miR-335 is downreg ......" | 25492484 | |
| hsa-miR-335-5p | colorectal cancer | upregulation | "Expression of target miRs in micro-dissected paraf ......" | 22120473 | qPCR |
| hsa-miR-335-5p | colorectal cancer | upregulation | "Quantitative reverse-transcription PCR was used to ......" | 23267864 | Reverse transcription PCR |
| hsa-miR-335-5p | colorectal cancer | upregulation | "The involvement of miR-335 in csolorectal cancer C ......" | 26708214 | |
| hsa-miR-335-5p | gastric cancer | downregulation | "The clinical significance of downregulation of mir ......" | 24805774 | Microarray |
| hsa-miR-335-5p | gastric cancer | downregulation | "miR-335 and miR-34a are two microRNAs miRNAs usual ......" | 26318298 | Microarray; qPCR |
| hsa-miR-335-5p | kidney renal cell cancer | downregulation | "We analyzed 70 matched pairs of clear cell renal c ......" | 21784468 | qPCR; Microarray |
| hsa-miR-335-5p | kidney renal cell cancer | downregulation | "Recent studies have shown that microRNA-335 miR-33 ......" | 25846734 | |
| hsa-miR-335-5p | liver cancer | downregulation | "Previous miRNA microarray analysis illustrated tha ......" | 25804796 | Microarray; qPCR |
| hsa-miR-335-5p | lung cancer | upregulation | "Effect of miR 335 upregulation on the apoptosis an ......" | 23740614 | qPCR |
| hsa-miR-335-5p | ovarian cancer | downregulation | "Although aberrant expression of miR-335 has been r ......" | 23708561 | qPCR |
| hsa-miR-335-5p | ovarian cancer | downregulation | "miR 335 represents an independent prognostic marke ......" | 24515774 | |
| hsa-miR-335-5p | prostate cancer | downregulation | "MicroRNA 335 acts as a candidate tumor suppressor ......" | 23456549 | in situ hybridization |
| hsa-miR-335-5p | sarcoma | deregulation | "The most significantly downregulated miRNAs were m ......" | 24027049 | |
| hsa-miR-335-5p | sarcoma | deregulation | "Previous studies have shown that miR-335 plays an ......" | 27097943 | qPCR |
Reported cancer pathway affected by hsa-miR-335-5p
| miRNA | cancer | pathway | reporting | PUBMED | functional study |
|---|---|---|---|---|---|
| hsa-miR-335-5p | breast cancer | Apoptosis pathway | "MicroRNA miR 335 is crucial for the BRCA1 regulato ......" | 21618216 | Luciferase |
| hsa-miR-335-5p | breast cancer | cell cycle pathway | "microRNA 335 inhibits proliferation cell cycle pro ......" | 25323813 | Colony formation; Luciferase; Western blot |
| hsa-miR-335-5p | breast cancer | Apoptosis pathway | "Based on the results obtained in the last decade s ......" | 26199650 | |
| hsa-miR-335-5p | gastric cancer | Apoptosis pathway | "miR 335 directly while miR 34a indirectly modulate ......" | 26318298 | Western blot; Luciferase; Flow cytometry; Transwell assay |
| hsa-miR-335-5p | lung cancer | Apoptosis pathway | "Effect of miR 335 upregulation on the apoptosis an ......" | 23740614 | Western blot; Luciferase |
| hsa-miR-335-5p | sarcoma | Apoptosis pathway | "MiR 335 functions as a tumor suppressor and regula ......" | 27097943 | MTT assay; Western blot; Luciferase |
Reported cancer prognosis affected by hsa-miR-335-5p
| miRNA | cancer | prognosis | reporting | PUBMED | functional study |
|---|---|---|---|---|---|
| hsa-miR-335-5p | acute myeloid leukemia | progression; worse prognosis; poor survival | "High serum microRNA 335 level predicts aggressive ......" | 25301405 | |
| hsa-miR-335-5p | acute myeloid leukemia | worse prognosis; drug resistance; poor survival | "Bone Marrow MicroRNA 335 Level Predicts the Chemot ......" | 26287405 | |
| hsa-miR-335-5p | bladder cancer | cell migration | "MicroRNA 335 is downregulated in bladder cancer an ......" | 27035227 | Western blot; Luciferase |
| hsa-miR-335-5p | breast cancer | metastasis; poor survival | "Of these microRNAs miR-126 restoration reduces ove ......" | 18185580 | |
| hsa-miR-335-5p | breast cancer | metastasis | "The third identifies miR-335 miR-206 and miR-126 a ......" | 18373886 | |
| hsa-miR-335-5p | breast cancer | metastasis | "Genetic variants within miR 126 and miR 335 are no ......" | 21046227 | |
| hsa-miR-335-5p | breast cancer | malignant trasformation; metastasis; recurrence | "MicroRNA 335 inhibits tumor reinitiation and is si ......" | 21289068 | |
| hsa-miR-335-5p | breast cancer | metastasis | "Aryl hydrocarbon receptor agonists induce microRNA ......" | 22034498 | |
| hsa-miR-335-5p | breast cancer | metastasis | "Real Time RT-PCR was performed to identify the miR ......" | 22524830 | |
| hsa-miR-335-5p | breast cancer | staging; metastasis | "None of the investigated single miRNAs or miRNA cl ......" | 24196612 | |
| hsa-miR-335-5p | breast cancer | progression | "microRNA 335 inhibits proliferation cell cycle pro ......" | 25323813 | Colony formation; Luciferase; Western blot |
| hsa-miR-335-5p | breast cancer | metastasis; cell migration | "MiR 335 inhibits migration of breast cancer cells ......" | 25492484 | |
| hsa-miR-335-5p | breast cancer | metastasis; worse prognosis | "Based on the results obtained in the last decade s ......" | 26199650 | |
| hsa-miR-335-5p | breast cancer | metastasis | "Overexpression of Metastatic Related MicroRNAs Mir ......" | 26236665 | MTT assay |
| hsa-miR-335-5p | cervical and endocervical cancer | poor survival; worse prognosis | "MicroRNA 335 represents an independent prognostic ......" | 25712373 | |
| hsa-miR-335-5p | colorectal cancer | metastasis; progression | "Expression of target miRs in micro-dissected paraf ......" | 22120473 | |
| hsa-miR-335-5p | colorectal cancer | metastasis; poor survival; cell migration | "MicroRNA 335 inhibits invasion and metastasis of c ......" | 24829139 | Luciferase |
| hsa-miR-335-5p | colorectal cancer | differentiation | "Overexpression of miR 335 confers cell proliferati ......" | 26708214 | |
| hsa-miR-335-5p | esophageal cancer | worse prognosis; tumorigenesis; poor survival; malignant trasformation; staging; metastasis | "Up regulation of miR 335 predicts a favorable prog ......" | 25337272 | |
| hsa-miR-335-5p | gastric cancer | metastasis; progression; worse prognosis; cell migration; staging | "MicroRNA 335 acts as a metastasis suppressor in ga ......" | 21822301 | Western blot; Luciferase |
| hsa-miR-335-5p | gastric cancer | recurrence; poor survival; worse prognosis | "Identification of hsa miR 335 as a prognostic sign ......" | 22802949 | |
| hsa-miR-335-5p | gastric cancer | tumorigenesis; staging; metastasis; differentiation | "The clinical significance of downregulation of mir ......" | 24805774 | |
| hsa-miR-335-5p | gastric cancer | metastasis | "Methylation associated silencing of MicroRNA 335 c ......" | 25520857 | Western blot |
| hsa-miR-335-5p | gastric cancer | poor survival; staging; metastasis | "miR 335 directly while miR 34a indirectly modulate ......" | 26318298 | Western blot; Luciferase; Flow cytometry; Transwell assay |
| hsa-miR-335-5p | gastric cancer | progression | "Gastric cancer is the most common cancer in the wo ......" | 27044823 | |
| hsa-miR-335-5p | kidney renal cell cancer | staging; metastasis; tumor size | "miR 335 inhibits the proliferation and invasion of ......" | 25846734 | |
| hsa-miR-335-5p | liver cancer | metastasis | "Epigenetic silencing of miR 335 and its host gene ......" | 23229728 | |
| hsa-miR-335-5p | liver cancer | cell migration | "MiR 335 acts as a potential tumor suppressor miRNA ......" | 25804796 | Transwell assay; Western blot; Luciferase; MTT assay |
| hsa-miR-335-5p | liver cancer | worse prognosis; drug resistance; progression; tumor size | "Serum miR 335 Level is Associated with the Treatme ......" | 26305026 | |
| hsa-miR-335-5p | lung cancer | metastasis | "Effect of miR 335 upregulation on the apoptosis an ......" | 23740614 | Western blot; Luciferase |
| hsa-miR-335-5p | lung cancer | metastasis | "By developing an integrated bioinformatics analysi ......" | 26075299 | |
| hsa-miR-335-5p | lung squamous cell cancer | metastasis; cell migration | "miR 335 inhibits small cell lung cancer bone metas ......" | 23966614 | Colony formation |
| hsa-miR-335-5p | lung squamous cell cancer | drug resistance | "WW domain binding protein 5 induces multidrug resi ......" | 27336605 | Western blot |
| hsa-miR-335-5p | ovarian cancer | drug resistance | "High-throughput analysis of the miRNA profile in a ......" | 18823650 | |
| hsa-miR-335-5p | ovarian cancer | tumorigenesis; cell migration; poor survival; malignant trasformation | "miR 335 represents an invasion suppressor gene in ......" | 23708561 | |
| hsa-miR-335-5p | ovarian cancer | metastasis; malignant trasformation; recurrence; worse prognosis | "miR 335 represents an independent prognostic marke ......" | 24515774 | |
| hsa-miR-335-5p | ovarian cancer | drug resistance | "Analysis of microarray identified genes and microR ......" | 26261572 | |
| hsa-miR-335-5p | pancreatic cancer | metastasis; poor survival; progression | "MiR 335 functions as a tumor suppressor in pancrea ......" | 24859837 | Flow cytometry |
| hsa-miR-335-5p | prostate cancer | staging; metastasis; worse prognosis | "MicroRNA 335 acts as a candidate tumor suppressor ......" | 23456549 | |
| hsa-miR-335-5p | prostate cancer | metastasis | "MicroRNA 335 and 543 suppress bone metastasis in p ......" | 26647850 | Luciferase |
| hsa-miR-335-5p | sarcoma | metastasis; cell migration | "miR 335 suppresses migration and invasion by targe ......" | 23975506 | Luciferase |
| hsa-miR-335-5p | thyroid cancer | staging | "To elucidate the mechanisms undergoing the pathoge ......" | 23533107 |
Reported gene related to hsa-miR-335-5p
| miRNA | cancer | gene | reporting | PUBMED |
|---|---|---|---|---|
| hsa-miR-335-5p | gastric cancer | BCL2L2 | "MicroRNA 335 acts as a metastasis suppressor in ga ......" | 21822301 |
| hsa-miR-335-5p | kidney renal cell cancer | BCL2L2 | "miR 335 inhibits the proliferation and invasion of ......" | 25846734 |
| hsa-miR-335-5p | lung cancer | BCL2L2 | "Luciferase reporter assay and Western blot were to ......" | 23740614 |
| hsa-miR-335-5p | ovarian cancer | BCL2L2 | "miR 335 represents an invasion suppressor gene in ......" | 23708561 |
| hsa-miR-335-5p | bladder cancer | ROCK1 | "MicroRNA 335 is downregulated in bladder cancer an ......" | 27035227 |
| hsa-miR-335-5p | liver cancer | ROCK1 | "MiR 335 acts as a potential tumor suppressor miRNA ......" | 25804796 |
| hsa-miR-335-5p | sarcoma | ROCK1 | "miR 335 suppresses migration and invasion by targe ......" | 23975506 |
| hsa-miR-335-5p | colorectal cancer | RASA1 | "Forced expression of miR-335 silenced RASA1 and tr ......" | 26708214 |
| hsa-miR-335-5p | gastric cancer | RASA1 | "Methylation associated silencing of MicroRNA 335 c ......" | 25520857 |
| hsa-miR-335-5p | gastric cancer | SP1 | "MicroRNA 335 acts as a metastasis suppressor in ga ......" | 21822301 |
| hsa-miR-335-5p | lung cancer | SP1 | "Luciferase reporter assay and Western blot were to ......" | 23740614 |
| hsa-miR-335-5p | lung squamous cell cancer | ABCC11 | "WW domain binding protein 5 induces multidrug resi ......" | 27336605 |
| hsa-miR-335-5p | liver cancer | AFP | "Lower serum miR-335 levels were closely associated ......" | 26305026 |
| hsa-miR-335-5p | breast cancer | AHR | "Aryl hydrocarbon receptor agonists induce microRNA ......" | 22034498 |
| hsa-miR-335-5p | lung cancer | BIRC5 | "Genetic variation in a miR 335 binding site in BIR ......" | 23232114 |
| hsa-miR-335-5p | breast cancer | BRCA1 | "MicroRNA miR 335 is crucial for the BRCA1 regulato ......" | 21618216 |
| hsa-miR-335-5p | sarcoma | CASP3 | "The effect of miR-335 on apoptosis was measured by ......" | 27097943 |
| hsa-miR-335-5p | breast cancer | ESR1 | "Aryl hydrocarbon receptor agonists induce microRNA ......" | 22034498 |
| hsa-miR-335-5p | gastric cancer | F2 | "Low expression of miR-335 was significantly associ ......" | 21822301 |
| hsa-miR-335-5p | ovarian cancer | FRTS1 | "Low miR-335 levels in EOC were associated with sho ......" | 24515774 |
| hsa-miR-335-5p | gastric cancer | IBSP | "Subsequently in GC cells and tissues we performed ......" | 25520857 |
| hsa-miR-335-5p | breast cancer | ID4 | "Overexpression of miR-335 resulted in an upregulat ......" | 21618216 |
| hsa-miR-335-5p | lung squamous cell cancer | INSR | "miR 335 inhibits small cell lung cancer bone metas ......" | 23966614 |
| hsa-miR-335-5p | liver cancer | MEST | "Epigenetic silencing of miR 335 and its host gene ......" | 23229728 |
| hsa-miR-335-5p | breast cancer | MET | "MiR 335 inhibits migration of breast cancer cells ......" | 25492484 |
| hsa-miR-335-5p | prostate cancer | NOA1 | "MicroRNA 335 and 543 suppress bone metastasis in p ......" | 26647850 |
| hsa-miR-335-5p | breast cancer | PAX6 | "microRNA 335 inhibits proliferation cell cycle pro ......" | 25323813 |
| hsa-miR-335-5p | lung squamous cell cancer | SCLC1 | "Because microRNAs miRNA often act as tumor regulat ......" | 23966614 |
| hsa-miR-335-5p | breast cancer | SETBP1 | "Herein we evaluated the effect of SEB on the expre ......" | 26236665 |
| hsa-miR-335-5p | breast cancer | SOX4 | "Both TCDD and MCDF induced miR-335 in MDA-MB-231 a ......" | 22034498 |
| hsa-miR-335-5p | lung squamous cell cancer | TNFSF11 | "miR 335 inhibits small cell lung cancer bone metas ......" | 23966614 |
| hsa-miR-335-5p | lung squamous cell cancer | WBP5 | "We also found that miR-335 negatively regulated th ......" | 27336605 |
| hsa-miR-335-5p | colorectal cancer | ZEB2 | "MicroRNA 335 inhibits invasion and metastasis of c ......" | 24829139 |
Expression profile in cancer corhorts:
Putative target regulations
| miRNA | Gene | Cancer | Interaction | Correlation beta |
|---|---|---|---|---|
hsa-miR-335-5p | ACVR1 | 12 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.138; TCGA CESC -0.093; TCGA COAD -0.079; TCGA ESCA -0.129; TCGA HNSC -0.086; TCGA LUAD -0.079; TCGA LUSC -0.112; TCGA PAAD -0.184; TCGA PRAD -0.066; TCGA THCA -0.163; TCGA STAD -0.061; TCGA UCEC -0.085 |
hsa-miR-335-5p | ADAMTS12 | 10 cancers: BLCA; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; THCA | miRNAWalker2 validate | TCGA BLCA -0.196; TCGA COAD -0.962; TCGA ESCA -0.228; TCGA HNSC -0.279; TCGA LGG -0.203; TCGA LUAD -0.386; TCGA LUSC -0.497; TCGA PAAD -0.988; TCGA PRAD -0.259; TCGA THCA -0.44 |
hsa-miR-335-5p | ADCY7 | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUSC; THCA; STAD | miRNAWalker2 validate | TCGA BLCA -0.109; TCGA CESC -0.152; TCGA COAD -0.265; TCGA ESCA -0.219; TCGA HNSC -0.233; TCGA KIRC -0.205; TCGA KIRP -0.087; TCGA LUSC -0.083; TCGA THCA -0.43; TCGA STAD -0.092 |
hsa-miR-335-5p | AHNAK | 12 cancers: BLCA; CESC; COAD; ESCA; HNSC; LGG; LUSC; PAAD; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.162; TCGA CESC -0.206; TCGA COAD -0.471; TCGA ESCA -0.352; TCGA HNSC -0.108; TCGA LGG -0.091; TCGA LUSC -0.111; TCGA PAAD -0.247; TCGA PRAD -0.185; TCGA THCA -0.1; TCGA STAD -0.345; TCGA UCEC -0.171 |
hsa-miR-335-5p | AKAP13 | 10 cancers: BLCA; CESC; COAD; ESCA; KIRC; PAAD; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.097; TCGA CESC -0.149; TCGA COAD -0.249; TCGA ESCA -0.131; TCGA KIRC -0.087; TCGA PAAD -0.17; TCGA PRAD -0.084; TCGA THCA -0.095; TCGA STAD -0.081; TCGA UCEC -0.099 |
hsa-miR-335-5p | ANKRD29 | 9 cancers: BLCA; CESC; ESCA; HNSC; KIRC; LIHC; SARC; THCA; STAD | miRNAWalker2 validate | TCGA BLCA -0.515; TCGA CESC -0.235; TCGA ESCA -0.496; TCGA HNSC -0.225; TCGA KIRC -0.113; TCGA LIHC -0.257; TCGA SARC -0.248; TCGA THCA -0.209; TCGA STAD -0.332 |
hsa-miR-335-5p | ANTXR2 | 12 cancers: BLCA; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.282; TCGA COAD -0.319; TCGA ESCA -0.197; TCGA HNSC -0.26; TCGA LUAD -0.11; TCGA LUSC -0.197; TCGA PAAD -0.294; TCGA PRAD -0.154; TCGA SARC -0.067; TCGA THCA -0.188; TCGA STAD -0.335; TCGA UCEC -0.234 |
hsa-miR-335-5p | ANXA1 | 11 cancers: BLCA; CESC; COAD; ESCA; KIRC; KIRP; PAAD; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.135; TCGA CESC -0.294; TCGA COAD -0.54; TCGA ESCA -0.316; TCGA KIRC -0.131; TCGA KIRP -0.119; TCGA PAAD -0.368; TCGA PRAD -0.121; TCGA THCA -0.418; TCGA STAD -0.142; TCGA UCEC -0.188 |
hsa-miR-335-5p | APCDD1L | 11 cancers: BLCA; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.389; TCGA COAD -1.066; TCGA ESCA -0.674; TCGA HNSC -0.228; TCGA LUAD -0.602; TCGA LUSC -0.507; TCGA PAAD -0.314; TCGA PRAD -0.189; TCGA THCA -0.874; TCGA STAD -0.252; TCGA UCEC -0.204 |
hsa-miR-335-5p | APOL2 | 12 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; LIHC; LUAD; PAAD; SARC; THCA | miRNAWalker2 validate | TCGA BLCA -0.064; TCGA BRCA -0.064; TCGA CESC -0.15; TCGA COAD -0.325; TCGA HNSC -0.141; TCGA KIRC -0.065; TCGA KIRP -0.068; TCGA LIHC -0.064; TCGA LUAD -0.149; TCGA PAAD -0.112; TCGA SARC -0.096; TCGA THCA -0.211 |
hsa-miR-335-5p | ARHGEF37 | 9 cancers: BLCA; CESC; ESCA; HNSC; KIRC; LGG; LIHC; PRAD; STAD | miRNAWalker2 validate | TCGA BLCA -0.245; TCGA CESC -0.15; TCGA ESCA -0.343; TCGA HNSC -0.199; TCGA KIRC -0.153; TCGA LGG -0.08; TCGA LIHC -0.252; TCGA PRAD -0.086; TCGA STAD -0.19 |
hsa-miR-335-5p | ARHGEF4 | 9 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PRAD; STAD | miRNAWalker2 validate | TCGA BLCA -0.274; TCGA CESC -0.248; TCGA COAD -0.349; TCGA ESCA -0.57; TCGA HNSC -0.292; TCGA LUAD -0.181; TCGA LUSC -0.193; TCGA PRAD -0.151; TCGA STAD -0.338 |
hsa-miR-335-5p | ARNTL | 11 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LUSC; PAAD; PRAD; THCA; UCEC | miRNAWalker2 validate | TCGA BLCA -0.164; TCGA CESC -0.145; TCGA COAD -0.102; TCGA ESCA -0.185; TCGA HNSC -0.063; TCGA KIRC -0.089; TCGA LUSC -0.063; TCGA PAAD -0.135; TCGA PRAD -0.162; TCGA THCA -0.378; TCGA UCEC -0.119 |
hsa-miR-335-5p | ARSI | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; THCA | miRNAWalker2 validate | TCGA BLCA -0.36; TCGA BRCA -0.257; TCGA CESC -0.288; TCGA COAD -0.811; TCGA ESCA -0.599; TCGA HNSC -0.555; TCGA LUAD -0.172; TCGA LUSC -0.401; TCGA PAAD -0.696; TCGA PRAD -0.188; TCGA THCA -0.954 |
hsa-miR-335-5p | ASB2 | 9 cancers: BLCA; CESC; COAD; ESCA; KIRC; PRAD; SARC; THCA; STAD | miRNAWalker2 validate | TCGA BLCA -0.423; TCGA CESC -0.348; TCGA COAD -0.657; TCGA ESCA -0.556; TCGA KIRC -0.154; TCGA PRAD -0.357; TCGA SARC -0.484; TCGA THCA -0.411; TCGA STAD -0.535 |
hsa-miR-335-5p | ASPN | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; THCA; STAD | miRNAWalker2 validate | TCGA BLCA -0.22; TCGA BRCA -0.201; TCGA CESC -0.281; TCGA COAD -0.838; TCGA ESCA -0.319; TCGA HNSC -0.203; TCGA LUAD -0.314; TCGA LUSC -0.573; TCGA PAAD -0.629; TCGA THCA -0.396; TCGA STAD -0.399 |
hsa-miR-335-5p | ATP10D | 9 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUSC; PRAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.169; TCGA CESC -0.219; TCGA COAD -0.256; TCGA ESCA -0.389; TCGA HNSC -0.235; TCGA LUSC -0.202; TCGA PRAD -0.159; TCGA STAD -0.187; TCGA UCEC -0.17 |
hsa-miR-335-5p | ATP2B4 | 13 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LIHC; LUSC; PAAD; PRAD; SARC; THCA; STAD | miRNAWalker2 validate; MirTarget | TCGA BLCA -0.201; TCGA CESC -0.11; TCGA COAD -0.471; TCGA ESCA -0.366; TCGA HNSC -0.079; TCGA KIRC -0.064; TCGA LIHC -0.097; TCGA LUSC -0.144; TCGA PAAD -0.153; TCGA PRAD -0.297; TCGA SARC -0.08; TCGA THCA -0.137; TCGA STAD -0.377 |
hsa-miR-335-5p | ATXN1 | 9 cancers: BLCA; COAD; ESCA; KIRC; LUAD; LUSC; PAAD; PRAD; STAD | miRNAWalker2 validate | TCGA BLCA -0.223; TCGA COAD -0.145; TCGA ESCA -0.179; TCGA KIRC -0.071; TCGA LUAD -0.075; TCGA LUSC -0.092; TCGA PAAD -0.244; TCGA PRAD -0.109; TCGA STAD -0.166 |
hsa-miR-335-5p | BCL2A1 | 10 cancers: BLCA; BRCA; COAD; KIRC; KIRP; LUSC; PAAD; SARC; THCA; UCEC | miRNAWalker2 validate | TCGA BLCA -0.219; TCGA BRCA -0.136; TCGA COAD -0.63; TCGA KIRC -0.228; TCGA KIRP -0.188; TCGA LUSC -0.208; TCGA PAAD -0.332; TCGA SARC -0.166; TCGA THCA -0.705; TCGA UCEC -0.14 |
hsa-miR-335-5p | BHLHE40 | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUAD; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.135; TCGA CESC -0.247; TCGA COAD -0.169; TCGA ESCA -0.214; TCGA HNSC -0.087; TCGA LUAD -0.125; TCGA PRAD -0.14; TCGA THCA -0.483; TCGA STAD -0.097; TCGA UCEC -0.173 |
hsa-miR-335-5p | BMP1 | 11 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; THCA | miRNAWalker2 validate | TCGA BLCA -0.106; TCGA BRCA -0.116; TCGA COAD -0.279; TCGA ESCA -0.202; TCGA HNSC -0.19; TCGA KIRC -0.16; TCGA LUAD -0.254; TCGA LUSC -0.22; TCGA PAAD -0.336; TCGA PRAD -0.077; TCGA THCA -0.189 |
hsa-miR-335-5p | BTN3A1 | 9 cancers: BLCA; CESC; COAD; HNSC; KIRC; KIRP; LIHC; PRAD; THCA | miRNAWalker2 validate | TCGA BLCA -0.101; TCGA CESC -0.109; TCGA COAD -0.166; TCGA HNSC -0.12; TCGA KIRC -0.287; TCGA KIRP -0.058; TCGA LIHC -0.193; TCGA PRAD -0.057; TCGA THCA -0.31 |
hsa-miR-335-5p | C1QA | 10 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; PAAD; THCA; UCEC | miRNAWalker2 validate | TCGA BLCA -0.27; TCGA BRCA -0.054; TCGA CESC -0.202; TCGA COAD -0.564; TCGA ESCA -0.185; TCGA HNSC -0.119; TCGA KIRC -0.238; TCGA PAAD -0.181; TCGA THCA -0.496; TCGA UCEC -0.143 |
hsa-miR-335-5p | C1S | 11 cancers: BLCA; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | miRNAWalker2 validate | TCGA BLCA -0.363; TCGA COAD -0.683; TCGA ESCA -0.389; TCGA HNSC -0.162; TCGA LUAD -0.211; TCGA LUSC -0.316; TCGA PAAD -0.479; TCGA PRAD -0.181; TCGA SARC -0.192; TCGA THCA -0.522; TCGA STAD -0.181 |
hsa-miR-335-5p | CD14 | 10 cancers: BLCA; CESC; COAD; ESCA; KIRC; LUAD; LUSC; PAAD; PRAD; THCA | miRNAWalker2 validate | TCGA BLCA -0.284; TCGA CESC -0.132; TCGA COAD -0.564; TCGA ESCA -0.17; TCGA KIRC -0.121; TCGA LUAD -0.153; TCGA LUSC -0.178; TCGA PAAD -0.144; TCGA PRAD -0.075; TCGA THCA -0.24 |
hsa-miR-335-5p | CD300C | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; PAAD; SARC; THCA | miRNAWalker2 validate | TCGA BLCA -0.28; TCGA BRCA -0.066; TCGA CESC -0.213; TCGA COAD -0.594; TCGA ESCA -0.163; TCGA HNSC -0.121; TCGA KIRC -0.255; TCGA KIRP -0.108; TCGA PAAD -0.223; TCGA SARC -0.099; TCGA THCA -0.19 |
hsa-miR-335-5p | CD33 | 10 cancers: BLCA; CESC; COAD; ESCA; KIRC; PAAD; PRAD; SARC; THCA; STAD | miRNAWalker2 validate | TCGA BLCA -0.239; TCGA CESC -0.239; TCGA COAD -0.67; TCGA ESCA -0.285; TCGA KIRC -0.234; TCGA PAAD -0.204; TCGA PRAD -0.084; TCGA SARC -0.134; TCGA THCA -0.55; TCGA STAD -0.126 |
hsa-miR-335-5p | CD38 | 9 cancers: BLCA; CESC; COAD; ESCA; KIRC; PAAD; PRAD; THCA; STAD | miRNAWalker2 validate | TCGA BLCA -0.284; TCGA CESC -0.304; TCGA COAD -0.656; TCGA ESCA -0.274; TCGA KIRC -0.177; TCGA PAAD -0.368; TCGA PRAD -0.388; TCGA THCA -0.479; TCGA STAD -0.179 |
hsa-miR-335-5p | CD69 | 9 cancers: BLCA; CESC; COAD; ESCA; KIRC; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.161; TCGA CESC -0.281; TCGA COAD -0.535; TCGA ESCA -0.188; TCGA KIRC -0.16; TCGA SARC -0.159; TCGA THCA -0.649; TCGA STAD -0.209; TCGA UCEC -0.159 |
hsa-miR-335-5p | CDH11 | 11 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; THCA; STAD | miRNAWalker2 validate | TCGA BLCA -0.133; TCGA BRCA -0.15; TCGA COAD -0.599; TCGA ESCA -0.283; TCGA HNSC -0.157; TCGA LUAD -0.235; TCGA LUSC -0.306; TCGA PAAD -0.694; TCGA PRAD -0.107; TCGA THCA -0.724; TCGA STAD -0.165 |
hsa-miR-335-5p | CDKN1A | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; THCA | miRNAWalker2 validate | TCGA BLCA -0.153; TCGA CESC -0.251; TCGA COAD -0.131; TCGA ESCA -0.323; TCGA HNSC -0.234; TCGA KIRC -0.129; TCGA KIRP -0.089; TCGA LUAD -0.086; TCGA LUSC -0.15; TCGA THCA -0.356 |
hsa-miR-335-5p | CLIC2 | 10 cancers: BLCA; CESC; COAD; ESCA; KIRC; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.163; TCGA CESC -0.301; TCGA COAD -0.462; TCGA ESCA -0.144; TCGA KIRC -0.115; TCGA PRAD -0.115; TCGA SARC -0.085; TCGA THCA -0.119; TCGA STAD -0.191; TCGA UCEC -0.152 |
hsa-miR-335-5p | CLIC4 | 12 cancers: BLCA; COAD; ESCA; HNSC; KIRC; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.254; TCGA COAD -0.318; TCGA ESCA -0.304; TCGA HNSC -0.133; TCGA KIRC -0.057; TCGA LUSC -0.118; TCGA PAAD -0.437; TCGA PRAD -0.2; TCGA SARC -0.092; TCGA THCA -0.114; TCGA STAD -0.337; TCGA UCEC -0.285 |
hsa-miR-335-5p | COL15A1 | 12 cancers: BLCA; CESC; COAD; ESCA; KIRC; LIHC; LUAD; LUSC; PAAD; PRAD; THCA; STAD | miRNAWalker2 validate | TCGA BLCA -0.118; TCGA CESC -0.148; TCGA COAD -0.593; TCGA ESCA -0.142; TCGA KIRC -0.145; TCGA LIHC -0.352; TCGA LUAD -0.388; TCGA LUSC -0.43; TCGA PAAD -0.403; TCGA PRAD -0.114; TCGA THCA -0.145; TCGA STAD -0.172 |
hsa-miR-335-5p | COL3A1 | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; THCA | miRNAWalker2 validate | TCGA BLCA -0.177; TCGA BRCA -0.177; TCGA CESC -0.21; TCGA COAD -0.795; TCGA ESCA -0.39; TCGA HNSC -0.322; TCGA LUAD -0.461; TCGA LUSC -0.529; TCGA PAAD -0.84; TCGA PRAD -0.122; TCGA THCA -0.608 |
hsa-miR-335-5p | COL6A1 | 11 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; THCA; STAD | miRNAWalker2 validate | TCGA BLCA -0.227; TCGA BRCA -0.114; TCGA COAD -0.588; TCGA ESCA -0.415; TCGA HNSC -0.218; TCGA LUAD -0.365; TCGA LUSC -0.329; TCGA PAAD -0.445; TCGA PRAD -0.168; TCGA THCA -0.141; TCGA STAD -0.191 |
hsa-miR-335-5p | COL8A2 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | miRNAWalker2 validate | TCGA BLCA -0.28; TCGA BRCA -0.13; TCGA CESC -0.172; TCGA COAD -0.689; TCGA ESCA -0.563; TCGA HNSC -0.169; TCGA LUAD -0.443; TCGA LUSC -0.398; TCGA PAAD -0.589; TCGA PRAD -0.119; TCGA SARC -0.159; TCGA THCA -0.494; TCGA STAD -0.341 |
hsa-miR-335-5p | CPEB2 | 11 cancers: BLCA; CESC; ESCA; HNSC; KIRC; KIRP; LUSC; SARC; THCA; STAD; UCEC | miRNAWalker2 validate; miRNATAP | TCGA BLCA -0.19; TCGA CESC -0.143; TCGA ESCA -0.262; TCGA HNSC -0.234; TCGA KIRC -0.15; TCGA KIRP -0.064; TCGA LUSC -0.082; TCGA SARC -0.151; TCGA THCA -0.088; TCGA STAD -0.223; TCGA UCEC -0.154 |
hsa-miR-335-5p | CPEB4 | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUSC; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate; miRNATAP | TCGA BLCA -0.115; TCGA CESC -0.235; TCGA COAD -0.143; TCGA ESCA -0.146; TCGA HNSC -0.08; TCGA LUSC -0.095; TCGA PRAD -0.173; TCGA SARC -0.138; TCGA STAD -0.169; TCGA UCEC -0.174 |
hsa-miR-335-5p | CRISPLD2 | 12 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.208; TCGA CESC -0.187; TCGA COAD -0.563; TCGA ESCA -0.331; TCGA HNSC -0.169; TCGA LUAD -0.128; TCGA LUSC -0.258; TCGA PAAD -0.478; TCGA PRAD -0.134; TCGA THCA -0.227; TCGA STAD -0.288; TCGA UCEC -0.122 |
hsa-miR-335-5p | CSF1 | 10 cancers: BLCA; COAD; ESCA; KIRC; LGG; LUAD; LUSC; PRAD; THCA; UCEC | miRNAWalker2 validate | TCGA BLCA -0.322; TCGA COAD -0.487; TCGA ESCA -0.124; TCGA KIRC -0.074; TCGA LGG -0.133; TCGA LUAD -0.251; TCGA LUSC -0.124; TCGA PRAD -0.19; TCGA THCA -0.327; TCGA UCEC -0.128 |
hsa-miR-335-5p | CTHRC1 | 10 cancers: BLCA; BRCA; COAD; HNSC; KIRC; LUAD; LUSC; PAAD; THCA; UCEC | miRNAWalker2 validate | TCGA BLCA -0.208; TCGA BRCA -0.288; TCGA COAD -0.737; TCGA HNSC -0.234; TCGA KIRC -0.231; TCGA LUAD -0.38; TCGA LUSC -0.438; TCGA PAAD -0.773; TCGA THCA -0.833; TCGA UCEC -0.186 |
hsa-miR-335-5p | CTSD | 11 cancers: BLCA; BRCA; CESC; COAD; HNSC; LIHC; LUAD; LUSC; SARC; THCA; UCEC | miRNAWalker2 validate | TCGA BLCA -0.06; TCGA BRCA -0.194; TCGA CESC -0.077; TCGA COAD -0.171; TCGA HNSC -0.05; TCGA LIHC -0.14; TCGA LUAD -0.076; TCGA LUSC -0.092; TCGA SARC -0.1; TCGA THCA -0.205; TCGA UCEC -0.083 |
hsa-miR-335-5p | CXCL9 | 10 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; PAAD; SARC; THCA; UCEC | miRNAWalker2 validate | TCGA BLCA -0.312; TCGA BRCA -0.203; TCGA CESC -0.406; TCGA COAD -0.7; TCGA HNSC -0.346; TCGA KIRC -0.436; TCGA PAAD -0.358; TCGA SARC -0.221; TCGA THCA -0.854; TCGA UCEC -0.225 |
hsa-miR-335-5p | CYTH3 | 9 cancers: BLCA; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.061; TCGA COAD -0.134; TCGA ESCA -0.126; TCGA HNSC -0.112; TCGA LUAD -0.124; TCGA LUSC -0.063; TCGA PAAD -0.199; TCGA STAD -0.134; TCGA UCEC -0.083 |
hsa-miR-335-5p | DAAM1 | 9 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUSC; PRAD; STAD; UCEC | miRNAWalker2 validate; MirTarget; miRNATAP | TCGA BLCA -0.089; TCGA CESC -0.19; TCGA COAD -0.159; TCGA ESCA -0.26; TCGA HNSC -0.151; TCGA LUSC -0.115; TCGA PRAD -0.146; TCGA STAD -0.141; TCGA UCEC -0.111 |
hsa-miR-335-5p | DAB2 | 10 cancers: BLCA; ESCA; KIRC; KIRP; LUAD; LUSC; PAAD; THCA; STAD; UCEC | miRNAWalker2 validate; miRNATAP | TCGA BLCA -0.147; TCGA ESCA -0.138; TCGA KIRC -0.135; TCGA KIRP -0.069; TCGA LUAD -0.089; TCGA LUSC -0.211; TCGA PAAD -0.282; TCGA THCA -0.114; TCGA STAD -0.117; TCGA UCEC -0.1 |
hsa-miR-335-5p | DCHS2 | 9 cancers: BLCA; COAD; ESCA; KIRC; LUAD; LUSC; PRAD; THCA; STAD | miRNAWalker2 validate | TCGA BLCA -0.29; TCGA COAD -0.845; TCGA ESCA -0.335; TCGA KIRC -0.134; TCGA LUAD -0.191; TCGA LUSC -0.222; TCGA PRAD -0.384; TCGA THCA -0.339; TCGA STAD -0.234 |
hsa-miR-335-5p | DOCK11 | 10 cancers: BLCA; CESC; ESCA; HNSC; KIRP; PAAD; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.281; TCGA CESC -0.149; TCGA ESCA -0.338; TCGA HNSC -0.153; TCGA KIRP -0.137; TCGA PAAD -0.294; TCGA PRAD -0.266; TCGA THCA -0.193; TCGA STAD -0.232; TCGA UCEC -0.177 |
hsa-miR-335-5p | DST | 10 cancers: BLCA; COAD; ESCA; HNSC; LGG; PAAD; PRAD; SARC; THCA; STAD | miRNAWalker2 validate | TCGA BLCA -0.101; TCGA COAD -0.205; TCGA ESCA -0.275; TCGA HNSC -0.119; TCGA LGG -0.119; TCGA PAAD -0.113; TCGA PRAD -0.102; TCGA SARC -0.061; TCGA THCA -0.487; TCGA STAD -0.192 |
hsa-miR-335-5p | EGFR | 10 cancers: BLCA; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; STAD | miRNAWalker2 validate | TCGA BLCA -0.108; TCGA COAD -0.104; TCGA ESCA -0.399; TCGA HNSC -0.132; TCGA KIRC -0.131; TCGA LUAD -0.184; TCGA LUSC -0.138; TCGA PAAD -0.349; TCGA PRAD -0.172; TCGA STAD -0.176 |
hsa-miR-335-5p | EHBP1L1 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.132; TCGA BRCA -0.103; TCGA CESC -0.149; TCGA COAD -0.198; TCGA ESCA -0.22; TCGA HNSC -0.152; TCGA KIRC -0.19; TCGA LUAD -0.217; TCGA PRAD -0.162; TCGA SARC -0.154; TCGA THCA -0.368; TCGA STAD -0.202; TCGA UCEC -0.12 |
hsa-miR-335-5p | EMP1 | 10 cancers: BLCA; CESC; COAD; ESCA; LUSC; PAAD; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.13; TCGA CESC -0.335; TCGA COAD -0.383; TCGA ESCA -0.175; TCGA LUSC -0.122; TCGA PAAD -0.291; TCGA PRAD -0.118; TCGA THCA -0.18; TCGA STAD -0.18; TCGA UCEC -0.176 |
hsa-miR-335-5p | ERAP1 | 9 cancers: BLCA; CESC; LIHC; LUSC; PAAD; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.093; TCGA CESC -0.136; TCGA LIHC -0.105; TCGA LUSC -0.14; TCGA PAAD -0.09; TCGA PRAD -0.138; TCGA THCA -0.152; TCGA STAD -0.086; TCGA UCEC -0.115 |
hsa-miR-335-5p | FAM114A1 | 12 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.082; TCGA CESC -0.123; TCGA COAD -0.338; TCGA ESCA -0.171; TCGA HNSC -0.095; TCGA LUAD -0.133; TCGA LUSC -0.129; TCGA PAAD -0.369; TCGA PRAD -0.207; TCGA THCA -0.193; TCGA STAD -0.135; TCGA UCEC -0.099 |
hsa-miR-335-5p | FAM26E | 10 cancers: BLCA; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.206; TCGA COAD -0.64; TCGA ESCA -0.253; TCGA HNSC -0.218; TCGA LUAD -0.096; TCGA LUSC -0.293; TCGA PAAD -0.463; TCGA PRAD -0.111; TCGA STAD -0.188; TCGA UCEC -0.156 |
hsa-miR-335-5p | FAM49A | 11 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; PAAD; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.112; TCGA CESC -0.209; TCGA COAD -0.772; TCGA ESCA -0.28; TCGA HNSC -0.098; TCGA KIRC -0.214; TCGA PAAD -0.332; TCGA PRAD -0.147; TCGA THCA -0.072; TCGA STAD -0.317; TCGA UCEC -0.131 |
hsa-miR-335-5p | FBLIM1 | 10 cancers: BLCA; BRCA; COAD; HNSC; LUAD; LUSC; PAAD; PRAD; SARC; THCA | miRNAWalker2 validate | TCGA BLCA -0.107; TCGA BRCA -0.076; TCGA COAD -0.065; TCGA HNSC -0.315; TCGA LUAD -0.12; TCGA LUSC -0.082; TCGA PAAD -0.216; TCGA PRAD -0.112; TCGA SARC -0.133; TCGA THCA -0.132 |
hsa-miR-335-5p | FBLN2 | 9 cancers: BLCA; COAD; ESCA; LUAD; LUSC; PAAD; PRAD; THCA; STAD | miRNAWalker2 validate | TCGA BLCA -0.209; TCGA COAD -0.836; TCGA ESCA -0.536; TCGA LUAD -0.306; TCGA LUSC -0.391; TCGA PAAD -0.449; TCGA PRAD -0.164; TCGA THCA -0.236; TCGA STAD -0.224 |
hsa-miR-335-5p | FGD6 | 10 cancers: BLCA; COAD; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.127; TCGA COAD -0.165; TCGA HNSC -0.135; TCGA KIRC -0.089; TCGA LUAD -0.176; TCGA LUSC -0.092; TCGA PAAD -0.342; TCGA PRAD -0.199; TCGA STAD -0.176; TCGA UCEC -0.078 |
hsa-miR-335-5p | FGL2 | 10 cancers: BLCA; CESC; COAD; ESCA; LUSC; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.378; TCGA CESC -0.211; TCGA COAD -0.548; TCGA ESCA -0.443; TCGA LUSC -0.177; TCGA PRAD -0.175; TCGA SARC -0.126; TCGA THCA -0.25; TCGA STAD -0.461; TCGA UCEC -0.227 |
hsa-miR-335-5p | FILIP1L | 9 cancers: BLCA; COAD; ESCA; LUAD; LUSC; PAAD; PRAD; THCA; STAD | miRNAWalker2 validate | TCGA BLCA -0.227; TCGA COAD -0.445; TCGA ESCA -0.325; TCGA LUAD -0.112; TCGA LUSC -0.146; TCGA PAAD -0.357; TCGA PRAD -0.318; TCGA THCA -0.169; TCGA STAD -0.229 |
hsa-miR-335-5p | FLYWCH1 | 9 cancers: BLCA; CESC; ESCA; HNSC; KIRC; LIHC; LUAD; SARC; STAD | miRNAWalker2 validate | TCGA BLCA -0.062; TCGA CESC -0.092; TCGA ESCA -0.22; TCGA HNSC -0.054; TCGA KIRC -0.054; TCGA LIHC -0.187; TCGA LUAD -0.12; TCGA SARC -0.058; TCGA STAD -0.071 |
hsa-miR-335-5p | FNDC1 | 9 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD | miRNAWalker2 validate | TCGA BLCA -0.227; TCGA BRCA -0.278; TCGA CESC -0.236; TCGA COAD -1.018; TCGA ESCA -0.409; TCGA HNSC -0.181; TCGA LUAD -0.495; TCGA LUSC -0.692; TCGA PAAD -0.964 |
hsa-miR-335-5p | FOLR2 | 9 cancers: BLCA; CESC; COAD; ESCA; LGG; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.236; TCGA CESC -0.169; TCGA COAD -0.603; TCGA ESCA -0.241; TCGA LGG -0.225; TCGA PRAD -0.115; TCGA THCA -0.357; TCGA STAD -0.185; TCGA UCEC -0.183 |
hsa-miR-335-5p | FOXO1 | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUSC; PAAD; PRAD; STAD; UCEC | miRNAWalker2 validate; MirTarget | TCGA BLCA -0.084; TCGA CESC -0.091; TCGA COAD -0.177; TCGA ESCA -0.205; TCGA HNSC -0.079; TCGA LUSC -0.124; TCGA PAAD -0.14; TCGA PRAD -0.123; TCGA STAD -0.105; TCGA UCEC -0.13 |
hsa-miR-335-5p | FPR1 | 9 cancers: BLCA; CESC; COAD; ESCA; KIRC; PAAD; PRAD; THCA; UCEC | miRNAWalker2 validate | TCGA BLCA -0.278; TCGA CESC -0.171; TCGA COAD -0.88; TCGA ESCA -0.179; TCGA KIRC -0.136; TCGA PAAD -0.375; TCGA PRAD -0.123; TCGA THCA -0.614; TCGA UCEC -0.201 |
hsa-miR-335-5p | GAL3ST4 | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; LUAD; LUSC; PAAD; THCA; STAD | miRNAWalker2 validate | TCGA BLCA -0.073; TCGA BRCA -0.123; TCGA CESC -0.156; TCGA COAD -0.249; TCGA ESCA -0.199; TCGA KIRC -0.278; TCGA LUAD -0.164; TCGA LUSC -0.128; TCGA PAAD -0.245; TCGA THCA -0.342; TCGA STAD -0.105 |
hsa-miR-335-5p | GBP2 | 16 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.126; TCGA CESC -0.242; TCGA COAD -0.338; TCGA ESCA -0.192; TCGA HNSC -0.134; TCGA KIRC -0.193; TCGA KIRP -0.088; TCGA LIHC -0.31; TCGA LUAD -0.185; TCGA LUSC -0.093; TCGA PAAD -0.358; TCGA PRAD -0.135; TCGA SARC -0.313; TCGA THCA -0.481; TCGA STAD -0.215; TCGA UCEC -0.25 |
hsa-miR-335-5p | GEM | 10 cancers: BLCA; COAD; ESCA; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.312; TCGA COAD -0.415; TCGA ESCA -0.23; TCGA LUSC -0.138; TCGA PAAD -0.399; TCGA PRAD -0.223; TCGA SARC -0.159; TCGA THCA -0.214; TCGA STAD -0.334; TCGA UCEC -0.149 |
hsa-miR-335-5p | GPR34 | 9 cancers: BLCA; CESC; COAD; KIRC; LUSC; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.254; TCGA CESC -0.261; TCGA COAD -0.446; TCGA KIRC -0.174; TCGA LUSC -0.208; TCGA PRAD -0.132; TCGA THCA -0.297; TCGA STAD -0.207; TCGA UCEC -0.223 |
hsa-miR-335-5p | GSN | 9 cancers: BLCA; COAD; ESCA; KIRC; LIHC; LUAD; PRAD; THCA; STAD | miRNAWalker2 validate | TCGA BLCA -0.177; TCGA COAD -0.271; TCGA ESCA -0.261; TCGA KIRC -0.111; TCGA LIHC -0.079; TCGA LUAD -0.078; TCGA PRAD -0.176; TCGA THCA -0.243; TCGA STAD -0.191 |
hsa-miR-335-5p | HTR7 | 9 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LUSC; PRAD; STAD | miRNAWalker2 validate | TCGA BLCA -0.311; TCGA CESC -0.613; TCGA COAD -0.505; TCGA ESCA -0.7; TCGA HNSC -0.616; TCGA KIRC -0.229; TCGA LUSC -0.38; TCGA PRAD -0.122; TCGA STAD -0.347 |
hsa-miR-335-5p | HTRA3 | 9 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; STAD | miRNAWalker2 validate | TCGA BLCA -0.287; TCGA BRCA -0.084; TCGA COAD -0.611; TCGA ESCA -0.349; TCGA HNSC -0.131; TCGA LUAD -0.365; TCGA LUSC -0.322; TCGA PAAD -0.458; TCGA STAD -0.135 |
hsa-miR-335-5p | ICAM1 | 9 cancers: BLCA; BRCA; COAD; KIRC; LUAD; PAAD; SARC; THCA; UCEC | miRNAWalker2 validate | TCGA BLCA -0.24; TCGA BRCA -0.084; TCGA COAD -0.463; TCGA KIRC -0.202; TCGA LUAD -0.18; TCGA PAAD -0.277; TCGA SARC -0.105; TCGA THCA -0.633; TCGA UCEC -0.162 |
hsa-miR-335-5p | IFI16 | 14 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.284; TCGA CESC -0.371; TCGA COAD -0.442; TCGA ESCA -0.409; TCGA HNSC -0.173; TCGA KIRC -0.166; TCGA LUAD -0.206; TCGA LUSC -0.148; TCGA PAAD -0.272; TCGA PRAD -0.141; TCGA SARC -0.062; TCGA THCA -0.351; TCGA STAD -0.184; TCGA UCEC -0.141 |
hsa-miR-335-5p | IGSF21 | 10 cancers: BLCA; BRCA; COAD; ESCA; KIRC; LIHC; LUAD; LUSC; SARC; THCA | miRNAWalker2 validate | TCGA BLCA -0.395; TCGA BRCA -0.115; TCGA COAD -0.675; TCGA ESCA -0.242; TCGA KIRC -0.178; TCGA LIHC -0.232; TCGA LUAD -0.387; TCGA LUSC -0.423; TCGA SARC -0.259; TCGA THCA -0.403 |
hsa-miR-335-5p | IL21R | 10 cancers: BLCA; BRCA; CESC; COAD; KIRC; LUAD; LUSC; PAAD; SARC; THCA | miRNAWalker2 validate | TCGA BLCA -0.171; TCGA BRCA -0.366; TCGA CESC -0.268; TCGA COAD -0.657; TCGA KIRC -0.257; TCGA LUAD -0.28; TCGA LUSC -0.199; TCGA PAAD -0.374; TCGA SARC -0.176; TCGA THCA -0.647 |
hsa-miR-335-5p | ITGA1 | 11 cancers: BLCA; COAD; ESCA; HNSC; KIRC; LUSC; PAAD; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.215; TCGA COAD -0.334; TCGA ESCA -0.19; TCGA HNSC -0.155; TCGA KIRC -0.125; TCGA LUSC -0.139; TCGA PAAD -0.331; TCGA PRAD -0.314; TCGA SARC -0.107; TCGA STAD -0.309; TCGA UCEC -0.149 |
hsa-miR-335-5p | ITGB2 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; LUAD; LUSC; PAAD; SARC; THCA; UCEC | miRNAWalker2 validate | TCGA BLCA -0.24; TCGA BRCA -0.151; TCGA CESC -0.252; TCGA COAD -0.738; TCGA ESCA -0.159; TCGA KIRC -0.274; TCGA LUAD -0.187; TCGA LUSC -0.182; TCGA PAAD -0.287; TCGA SARC -0.113; TCGA THCA -0.681; TCGA UCEC -0.121 |
hsa-miR-335-5p | ITGB5 | 9 cancers: BLCA; COAD; ESCA; HNSC; LUAD; PAAD; SARC; THCA; STAD | miRNAWalker2 validate | TCGA BLCA -0.116; TCGA COAD -0.132; TCGA ESCA -0.103; TCGA HNSC -0.09; TCGA LUAD -0.187; TCGA PAAD -0.358; TCGA SARC -0.094; TCGA THCA -0.127; TCGA STAD -0.077 |
hsa-miR-335-5p | ITPR1 | 9 cancers: BLCA; CESC; COAD; ESCA; LUSC; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.164; TCGA CESC -0.189; TCGA COAD -0.457; TCGA ESCA -0.324; TCGA LUSC -0.134; TCGA PRAD -0.296; TCGA SARC -0.229; TCGA STAD -0.273; TCGA UCEC -0.334 |
hsa-miR-335-5p | ITPRIP | 12 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LUSC; PAAD; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.191; TCGA CESC -0.268; TCGA COAD -0.342; TCGA ESCA -0.392; TCGA HNSC -0.166; TCGA KIRC -0.212; TCGA LUSC -0.148; TCGA PAAD -0.263; TCGA PRAD -0.156; TCGA THCA -0.061; TCGA STAD -0.166; TCGA UCEC -0.103 |
hsa-miR-335-5p | JAK2 | 10 cancers: BLCA; CESC; COAD; HNSC; LUSC; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.14; TCGA CESC -0.21; TCGA COAD -0.271; TCGA HNSC -0.099; TCGA LUSC -0.099; TCGA PRAD -0.144; TCGA SARC -0.093; TCGA THCA -0.143; TCGA STAD -0.177; TCGA UCEC -0.194 |
hsa-miR-335-5p | KIAA1644 | 10 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LUSC; PAAD; PRAD; THCA; STAD | miRNAWalker2 validate; mirMAP | TCGA BLCA -0.429; TCGA BRCA -0.133; TCGA COAD -0.965; TCGA ESCA -0.587; TCGA HNSC -0.379; TCGA LUSC -0.337; TCGA PAAD -0.326; TCGA PRAD -0.295; TCGA THCA -0.301; TCGA STAD -0.563 |
hsa-miR-335-5p | KIRREL | 9 cancers: BLCA; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; STAD | miRNAWalker2 validate; mirMAP | TCGA BLCA -0.29; TCGA COAD -0.625; TCGA ESCA -0.319; TCGA HNSC -0.203; TCGA LUAD -0.138; TCGA LUSC -0.236; TCGA PAAD -0.547; TCGA PRAD -0.428; TCGA STAD -0.162 |
hsa-miR-335-5p | KLF13 | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; LIHC; LUSC; PAAD; PRAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.2; TCGA CESC -0.104; TCGA COAD -0.143; TCGA ESCA -0.115; TCGA HNSC -0.152; TCGA LIHC -0.077; TCGA LUSC -0.145; TCGA PAAD -0.119; TCGA PRAD -0.084; TCGA UCEC -0.151 |
hsa-miR-335-5p | KLF7 | 11 cancers: BLCA; CESC; ESCA; HNSC; KIRC; LUSC; PAAD; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate; mirMAP | TCGA BLCA -0.204; TCGA CESC -0.229; TCGA ESCA -0.539; TCGA HNSC -0.341; TCGA KIRC -0.091; TCGA LUSC -0.235; TCGA PAAD -0.239; TCGA PRAD -0.197; TCGA THCA -0.129; TCGA STAD -0.23; TCGA UCEC -0.106 |
hsa-miR-335-5p | KLHL5 | 12 cancers: BLCA; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.247; TCGA COAD -0.399; TCGA ESCA -0.171; TCGA HNSC -0.075; TCGA LGG -0.093; TCGA LUAD -0.12; TCGA LUSC -0.1; TCGA PAAD -0.299; TCGA PRAD -0.215; TCGA THCA -0.116; TCGA STAD -0.214; TCGA UCEC -0.134 |
hsa-miR-335-5p | L1CAM | 9 cancers: BLCA; COAD; ESCA; LUAD; LUSC; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.506; TCGA COAD -0.516; TCGA ESCA -0.301; TCGA LUAD -0.357; TCGA LUSC -0.224; TCGA PRAD -0.314; TCGA THCA -0.699; TCGA STAD -0.26; TCGA UCEC -0.381 |
hsa-miR-335-5p | LAPTM5 | 10 cancers: BLCA; BRCA; CESC; COAD; KIRC; LUAD; LUSC; PAAD; SARC; THCA | miRNAWalker2 validate | TCGA BLCA -0.168; TCGA BRCA -0.1; TCGA CESC -0.203; TCGA COAD -0.58; TCGA KIRC -0.277; TCGA LUAD -0.103; TCGA LUSC -0.137; TCGA PAAD -0.237; TCGA SARC -0.112; TCGA THCA -0.469 |
hsa-miR-335-5p | LILRB4 | 11 cancers: BLCA; BRCA; CESC; COAD; KIRC; KIRP; LUAD; LUSC; PAAD; SARC; THCA | miRNAWalker2 validate | TCGA BLCA -0.265; TCGA BRCA -0.165; TCGA CESC -0.335; TCGA COAD -0.887; TCGA KIRC -0.402; TCGA KIRP -0.155; TCGA LUAD -0.146; TCGA LUSC -0.216; TCGA PAAD -0.247; TCGA SARC -0.13; TCGA THCA -0.56 |
hsa-miR-335-5p | LILRB5 | 9 cancers: BLCA; COAD; ESCA; KIRC; LGG; PAAD; PRAD; THCA; STAD | miRNAWalker2 validate | TCGA BLCA -0.268; TCGA COAD -0.727; TCGA ESCA -0.329; TCGA KIRC -0.184; TCGA LGG -0.189; TCGA PAAD -0.383; TCGA PRAD -0.15; TCGA THCA -0.324; TCGA STAD -0.138 |
hsa-miR-335-5p | LMOD1 | 9 cancers: BLCA; COAD; ESCA; LGG; LUAD; PAAD; PRAD; SARC; STAD | miRNAWalker2 validate | TCGA BLCA -0.392; TCGA COAD -0.946; TCGA ESCA -0.672; TCGA LGG -0.112; TCGA LUAD -0.117; TCGA PAAD -0.491; TCGA PRAD -0.388; TCGA SARC -0.424; TCGA STAD -0.687 |
hsa-miR-335-5p | LOX | 12 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.191; TCGA CESC -0.237; TCGA COAD -0.638; TCGA ESCA -0.336; TCGA HNSC -0.306; TCGA KIRC -0.428; TCGA LUAD -0.18; TCGA LUSC -0.238; TCGA PAAD -0.716; TCGA THCA -0.766; TCGA STAD -0.13; TCGA UCEC -0.243 |
hsa-miR-335-5p | LRP1 | 11 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LIHC; LUAD; LUSC; PAAD; STAD | miRNAWalker2 validate | TCGA BLCA -0.173; TCGA CESC -0.293; TCGA COAD -0.191; TCGA ESCA -0.213; TCGA HNSC -0.073; TCGA KIRC -0.095; TCGA LIHC -0.098; TCGA LUAD -0.187; TCGA LUSC -0.182; TCGA PAAD -0.341; TCGA STAD -0.105 |
hsa-miR-335-5p | LRP10 | 9 cancers: BLCA; CESC; COAD; LGG; PAAD; PRAD; SARC; THCA; STAD | miRNAWalker2 validate; mirMAP | TCGA BLCA -0.09; TCGA CESC -0.125; TCGA COAD -0.198; TCGA LGG -0.056; TCGA PAAD -0.084; TCGA PRAD -0.121; TCGA SARC -0.091; TCGA THCA -0.076; TCGA STAD -0.075 |
hsa-miR-335-5p | LRRC8A | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LUAD; LUSC; THCA | miRNAWalker2 validate | TCGA BLCA -0.128; TCGA CESC -0.25; TCGA COAD -0.135; TCGA ESCA -0.247; TCGA HNSC -0.164; TCGA KIRC -0.136; TCGA LGG -0.186; TCGA LUAD -0.079; TCGA LUSC -0.153; TCGA THCA -0.051 |
hsa-miR-335-5p | LRRK2 | 10 cancers: BLCA; CESC; COAD; ESCA; KIRC; PAAD; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.283; TCGA CESC -0.293; TCGA COAD -0.733; TCGA ESCA -0.433; TCGA KIRC -0.199; TCGA PAAD -0.271; TCGA PRAD -0.312; TCGA THCA -0.651; TCGA STAD -0.459; TCGA UCEC -0.224 |
hsa-miR-335-5p | LSP1 | 9 cancers: BLCA; CESC; COAD; ESCA; KIRC; LUAD; LUSC; PAAD; THCA | miRNAWalker2 validate | TCGA BLCA -0.155; TCGA CESC -0.284; TCGA COAD -0.541; TCGA ESCA -0.2; TCGA KIRC -0.283; TCGA LUAD -0.146; TCGA LUSC -0.137; TCGA PAAD -0.237; TCGA THCA -0.52 |
hsa-miR-335-5p | LTBP1 | 11 cancers: BLCA; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | miRNAWalker2 validate | TCGA BLCA -0.085; TCGA COAD -0.48; TCGA ESCA -0.476; TCGA HNSC -0.257; TCGA LUAD -0.21; TCGA LUSC -0.142; TCGA PAAD -0.595; TCGA PRAD -0.173; TCGA SARC -0.092; TCGA THCA -0.627; TCGA STAD -0.324 |
hsa-miR-335-5p | LYST | 13 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.065; TCGA CESC -0.17; TCGA COAD -0.186; TCGA ESCA -0.155; TCGA HNSC -0.159; TCGA KIRC -0.093; TCGA LUAD -0.087; TCGA LUSC -0.122; TCGA PRAD -0.129; TCGA SARC -0.073; TCGA THCA -0.261; TCGA STAD -0.189; TCGA UCEC -0.125 |
hsa-miR-335-5p | MACF1 | 13 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.139; TCGA CESC -0.066; TCGA COAD -0.234; TCGA ESCA -0.305; TCGA HNSC -0.164; TCGA LUAD -0.066; TCGA LUSC -0.089; TCGA PAAD -0.12; TCGA PRAD -0.133; TCGA SARC -0.114; TCGA THCA -0.073; TCGA STAD -0.207; TCGA UCEC -0.15 |
hsa-miR-335-5p | MAFB | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.197; TCGA CESC -0.424; TCGA COAD -0.728; TCGA ESCA -0.468; TCGA HNSC -0.329; TCGA LGG -0.123; TCGA LUAD -0.149; TCGA LUSC -0.138; TCGA STAD -0.24; TCGA UCEC -0.152 |
hsa-miR-335-5p | MFGE8 | 11 cancers: BLCA; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | miRNAWalker2 validate | TCGA BLCA -0.221; TCGA COAD -0.505; TCGA ESCA -0.199; TCGA HNSC -0.073; TCGA LUAD -0.145; TCGA LUSC -0.147; TCGA PAAD -0.365; TCGA PRAD -0.115; TCGA SARC -0.129; TCGA THCA -0.404; TCGA STAD -0.079 |
hsa-miR-335-5p | MLXIP | 9 cancers: BLCA; COAD; HNSC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.108; TCGA COAD -0.119; TCGA HNSC -0.051; TCGA LUAD -0.109; TCGA LUSC -0.053; TCGA PAAD -0.105; TCGA PRAD -0.128; TCGA STAD -0.073; TCGA UCEC -0.068 |
hsa-miR-335-5p | MMP14 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; THCA; UCEC | miRNAWalker2 validate | TCGA BLCA -0.069; TCGA BRCA -0.209; TCGA CESC -0.095; TCGA COAD -0.451; TCGA ESCA -0.19; TCGA HNSC -0.176; TCGA KIRC -0.122; TCGA KIRP -0.141; TCGA LUAD -0.253; TCGA LUSC -0.228; TCGA PAAD -0.6; TCGA PRAD -0.108; TCGA THCA -0.334; TCGA UCEC -0.124 |
hsa-miR-335-5p | MMP2 | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; THCA | miRNAWalker2 validate; RAID | TCGA BLCA -0.202; TCGA CESC -0.171; TCGA COAD -0.763; TCGA ESCA -0.381; TCGA HNSC -0.214; TCGA LUAD -0.33; TCGA LUSC -0.412; TCGA PAAD -0.879; TCGA PRAD -0.15; TCGA THCA -0.264 |
hsa-miR-335-5p | MN1 | 10 cancers: BLCA; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | miRNAWalker2 validate; mirMAP | TCGA BLCA -0.293; TCGA COAD -0.559; TCGA ESCA -0.605; TCGA HNSC -0.334; TCGA LUAD -0.157; TCGA LUSC -0.219; TCGA PAAD -0.505; TCGA PRAD -0.175; TCGA STAD -0.305; TCGA UCEC -0.145 |
hsa-miR-335-5p | MS4A2 | 12 cancers: BLCA; CESC; COAD; ESCA; KIRC; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.243; TCGA CESC -0.359; TCGA COAD -0.753; TCGA ESCA -0.261; TCGA KIRC -0.363; TCGA LUSC -0.205; TCGA PAAD -0.305; TCGA PRAD -0.308; TCGA SARC -0.44; TCGA THCA -0.68; TCGA STAD -0.362; TCGA UCEC -0.251 |
hsa-miR-335-5p | NDRG1 | 9 cancers: BLCA; CESC; ESCA; HNSC; KIRC; LUAD; LUSC; SARC; UCEC | miRNAWalker2 validate | TCGA BLCA -0.116; TCGA CESC -0.322; TCGA ESCA -0.445; TCGA HNSC -0.38; TCGA KIRC -0.196; TCGA LUAD -0.104; TCGA LUSC -0.189; TCGA SARC -0.085; TCGA UCEC -0.262 |
hsa-miR-335-5p | NEURL1B | 9 cancers: BLCA; CESC; ESCA; KIRC; LUAD; LUSC; PRAD; THCA; STAD | miRNAWalker2 validate | TCGA BLCA -0.217; TCGA CESC -0.133; TCGA ESCA -0.116; TCGA KIRC -0.114; TCGA LUAD -0.117; TCGA LUSC -0.185; TCGA PRAD -0.226; TCGA THCA -0.158; TCGA STAD -0.119 |
hsa-miR-335-5p | NFIL3 | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; PAAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.215; TCGA CESC -0.075; TCGA COAD -0.075; TCGA ESCA -0.28; TCGA HNSC -0.102; TCGA KIRC -0.085; TCGA PAAD -0.177; TCGA THCA -0.175; TCGA STAD -0.066; TCGA UCEC -0.214 |
hsa-miR-335-5p | NLRP1 | 12 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PRAD; SARC; THCA; STAD | miRNAWalker2 validate | TCGA BLCA -0.134; TCGA CESC -0.289; TCGA COAD -0.513; TCGA ESCA -0.414; TCGA HNSC -0.17; TCGA KIRC -0.254; TCGA LUAD -0.12; TCGA LUSC -0.147; TCGA PRAD -0.145; TCGA SARC -0.088; TCGA THCA -0.115; TCGA STAD -0.173 |
hsa-miR-335-5p | NPC1 | 16 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.131; TCGA CESC -0.176; TCGA COAD -0.214; TCGA ESCA -0.106; TCGA HNSC -0.072; TCGA KIRC -0.065; TCGA KIRP -0.143; TCGA LIHC -0.062; TCGA LUAD -0.089; TCGA LUSC -0.062; TCGA PAAD -0.145; TCGA PRAD -0.067; TCGA SARC -0.165; TCGA THCA -0.34; TCGA STAD -0.08; TCGA UCEC -0.132 |
hsa-miR-335-5p | NR1D1 | 9 cancers: BLCA; CESC; HNSC; KIRC; KIRP; LUAD; LUSC; SARC; THCA | miRNAWalker2 validate | TCGA BLCA -0.152; TCGA CESC -0.248; TCGA HNSC -0.078; TCGA KIRC -0.227; TCGA KIRP -0.12; TCGA LUAD -0.217; TCGA LUSC -0.142; TCGA SARC -0.157; TCGA THCA -0.186 |
hsa-miR-335-5p | NRP1 | 11 cancers: BLCA; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.17; TCGA COAD -0.583; TCGA ESCA -0.175; TCGA HNSC -0.115; TCGA KIRC -0.167; TCGA LUAD -0.093; TCGA LUSC -0.13; TCGA PAAD -0.177; TCGA PRAD -0.095; TCGA STAD -0.118; TCGA UCEC -0.117 |
hsa-miR-335-5p | NRP2 | 14 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.306; TCGA CESC -0.128; TCGA COAD -0.634; TCGA ESCA -0.513; TCGA HNSC -0.123; TCGA KIRC -0.188; TCGA LUAD -0.133; TCGA LUSC -0.25; TCGA PAAD -0.388; TCGA PRAD -0.327; TCGA SARC -0.069; TCGA THCA -0.344; TCGA STAD -0.382; TCGA UCEC -0.235 |
hsa-miR-335-5p | NT5DC3 | 9 cancers: BLCA; ESCA; KIRC; LIHC; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate; mirMAP | TCGA BLCA -0.118; TCGA ESCA -0.121; TCGA KIRC -0.193; TCGA LIHC -0.079; TCGA PRAD -0.106; TCGA SARC -0.152; TCGA THCA -0.235; TCGA STAD -0.179; TCGA UCEC -0.125 |
hsa-miR-335-5p | NUPR1 | 12 cancers: BLCA; BRCA; CESC; ESCA; KIRC; KIRP; LGG; LIHC; LUAD; PAAD; SARC; STAD | miRNAWalker2 validate | TCGA BLCA -0.235; TCGA BRCA -0.119; TCGA CESC -0.219; TCGA ESCA -0.248; TCGA KIRC -0.16; TCGA KIRP -0.161; TCGA LGG -0.193; TCGA LIHC -0.365; TCGA LUAD -0.118; TCGA PAAD -0.303; TCGA SARC -0.098; TCGA STAD -0.185 |
hsa-miR-335-5p | ODF3B | 9 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; LUAD; SARC; THCA | miRNAWalker2 validate | TCGA BLCA -0.128; TCGA BRCA -0.109; TCGA CESC -0.136; TCGA COAD -0.253; TCGA ESCA -0.139; TCGA KIRC -0.501; TCGA LUAD -0.14; TCGA SARC -0.217; TCGA THCA -0.226 |
hsa-miR-335-5p | OPTN | 14 cancers: BLCA; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.137; TCGA COAD -0.101; TCGA ESCA -0.143; TCGA HNSC -0.108; TCGA KIRC -0.08; TCGA KIRP -0.069; TCGA LIHC -0.103; TCGA LUAD -0.073; TCGA LUSC -0.087; TCGA PRAD -0.15; TCGA SARC -0.09; TCGA THCA -0.262; TCGA STAD -0.091; TCGA UCEC -0.13 |
hsa-miR-335-5p | OSMR | 15 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.419; TCGA CESC -0.164; TCGA COAD -0.804; TCGA ESCA -0.282; TCGA HNSC -0.133; TCGA KIRC -0.128; TCGA KIRP -0.12; TCGA LUAD -0.261; TCGA LUSC -0.17; TCGA PAAD -0.47; TCGA PRAD -0.166; TCGA SARC -0.151; TCGA THCA -0.528; TCGA STAD -0.231; TCGA UCEC -0.223 |
hsa-miR-335-5p | P4HA3 | 9 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD | miRNAWalker2 validate | TCGA BLCA -0.238; TCGA BRCA -0.328; TCGA COAD -0.868; TCGA ESCA -0.338; TCGA HNSC -0.197; TCGA KIRC -0.299; TCGA LUAD -0.196; TCGA LUSC -0.23; TCGA PAAD -0.82 |
hsa-miR-335-5p | PCDHGC5 | 11 cancers: BLCA; CESC; ESCA; HNSC; KIRC; LUAD; LUSC; PRAD; SARC; THCA; STAD | miRNAWalker2 validate | TCGA BLCA -0.278; TCGA CESC -0.325; TCGA ESCA -0.678; TCGA HNSC -0.805; TCGA KIRC -0.23; TCGA LUAD -0.194; TCGA LUSC -0.252; TCGA PRAD -0.23; TCGA SARC -0.127; TCGA THCA -0.269; TCGA STAD -0.171 |
hsa-miR-335-5p | PDLIM4 | 10 cancers: BLCA; COAD; ESCA; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | miRNAWalker2 validate | TCGA BLCA -0.287; TCGA COAD -0.569; TCGA ESCA -0.462; TCGA LUAD -0.322; TCGA LUSC -0.176; TCGA PAAD -0.23; TCGA PRAD -0.11; TCGA SARC -0.096; TCGA THCA -0.818; TCGA STAD -0.193 |
hsa-miR-335-5p | PIK3CA | 9 cancers: BLCA; CESC; COAD; ESCA; PAAD; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.051; TCGA CESC -0.124; TCGA COAD -0.102; TCGA ESCA -0.143; TCGA PAAD -0.23; TCGA PRAD -0.123; TCGA THCA -0.113; TCGA STAD -0.157; TCGA UCEC -0.216 |
hsa-miR-335-5p | PLXNC1 | 12 cancers: BLCA; CESC; COAD; ESCA; KIRC; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.249; TCGA CESC -0.368; TCGA COAD -0.919; TCGA ESCA -0.217; TCGA KIRC -0.15; TCGA LUAD -0.185; TCGA LUSC -0.331; TCGA PAAD -0.373; TCGA PRAD -0.365; TCGA THCA -0.488; TCGA STAD -0.189; TCGA UCEC -0.236 |
hsa-miR-335-5p | PML | 11 cancers: BLCA; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; THCA | miRNAWalker2 validate | TCGA BLCA -0.117; TCGA COAD -0.166; TCGA ESCA -0.101; TCGA HNSC -0.208; TCGA KIRC -0.146; TCGA KIRP -0.05; TCGA LIHC -0.069; TCGA LUAD -0.165; TCGA LUSC -0.109; TCGA PAAD -0.119; TCGA THCA -0.148 |
hsa-miR-335-5p | PODN | 10 cancers: BLCA; CESC; COAD; ESCA; LGG; LUAD; LUSC; PAAD; PRAD; STAD | miRNAWalker2 validate | TCGA BLCA -0.149; TCGA CESC -0.239; TCGA COAD -0.618; TCGA ESCA -0.35; TCGA LGG -0.129; TCGA LUAD -0.189; TCGA LUSC -0.181; TCGA PAAD -0.344; TCGA PRAD -0.205; TCGA STAD -0.35 |
hsa-miR-335-5p | PPFIBP1 | 11 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LUSC; PAAD; PRAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.082; TCGA CESC -0.159; TCGA COAD -0.208; TCGA ESCA -0.24; TCGA HNSC -0.115; TCGA KIRC -0.069; TCGA LUSC -0.127; TCGA PAAD -0.242; TCGA PRAD -0.093; TCGA STAD -0.153; TCGA UCEC -0.099 |
hsa-miR-335-5p | PTAFR | 10 cancers: BLCA; CESC; COAD; LUAD; LUSC; PAAD; PRAD; SARC; THCA; UCEC | miRNAWalker2 validate | TCGA BLCA -0.211; TCGA CESC -0.31; TCGA COAD -0.816; TCGA LUAD -0.238; TCGA LUSC -0.268; TCGA PAAD -0.368; TCGA PRAD -0.196; TCGA SARC -0.112; TCGA THCA -0.428; TCGA UCEC -0.239 |
hsa-miR-335-5p | PTPN7 | 9 cancers: BLCA; BRCA; CESC; COAD; KIRC; LUAD; LUSC; SARC; THCA | miRNAWalker2 validate | TCGA BLCA -0.17; TCGA BRCA -0.132; TCGA CESC -0.248; TCGA COAD -0.439; TCGA KIRC -0.203; TCGA LUAD -0.166; TCGA LUSC -0.143; TCGA SARC -0.169; TCGA THCA -0.652 |
hsa-miR-335-5p | REEP3 | 12 cancers: BLCA; COAD; ESCA; HNSC; LGG; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.072; TCGA COAD -0.119; TCGA ESCA -0.139; TCGA HNSC -0.136; TCGA LGG -0.074; TCGA LUSC -0.115; TCGA PAAD -0.223; TCGA PRAD -0.088; TCGA SARC -0.055; TCGA THCA -0.081; TCGA STAD -0.177; TCGA UCEC -0.176 |
hsa-miR-335-5p | RGS18 | 10 cancers: BLCA; CESC; COAD; ESCA; KIRC; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.196; TCGA CESC -0.237; TCGA COAD -0.448; TCGA ESCA -0.166; TCGA KIRC -0.245; TCGA PRAD -0.165; TCGA SARC -0.113; TCGA THCA -0.473; TCGA STAD -0.125; TCGA UCEC -0.182 |
hsa-miR-335-5p | RNASE2 | 9 cancers: BLCA; BRCA; COAD; KIRC; KIRP; LUAD; LUSC; PAAD; THCA | miRNAWalker2 validate | TCGA BLCA -0.245; TCGA BRCA -0.124; TCGA COAD -0.41; TCGA KIRC -0.208; TCGA KIRP -0.136; TCGA LUAD -0.253; TCGA LUSC -0.15; TCGA PAAD -0.325; TCGA THCA -0.786 |
hsa-miR-335-5p | RNASEL | 9 cancers: BLCA; CESC; COAD; ESCA; LIHC; LUSC; PRAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.055; TCGA CESC -0.166; TCGA COAD -0.099; TCGA ESCA -0.092; TCGA LIHC -0.162; TCGA LUSC -0.126; TCGA PRAD -0.115; TCGA STAD -0.146; TCGA UCEC -0.183 |
hsa-miR-335-5p | RNF19B | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; SARC; THCA; UCEC | miRNAWalker2 validate | TCGA BLCA -0.086; TCGA BRCA -0.077; TCGA CESC -0.219; TCGA COAD -0.173; TCGA ESCA -0.152; TCGA HNSC -0.129; TCGA KIRC -0.065; TCGA LUAD -0.075; TCGA LUSC -0.197; TCGA SARC -0.095; TCGA THCA -0.226; TCGA UCEC -0.127 |
hsa-miR-335-5p | ROR2 | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; STAD | miRNAWalker2 validate | TCGA BLCA -0.434; TCGA BRCA -0.169; TCGA CESC -0.214; TCGA COAD -0.603; TCGA ESCA -0.529; TCGA HNSC -0.253; TCGA LUAD -0.3; TCGA LUSC -0.339; TCGA PAAD -0.521; TCGA PRAD -0.189; TCGA STAD -0.398 |
hsa-miR-335-5p | RORA | 9 cancers: BLCA; CESC; COAD; ESCA; KIRC; PAAD; PRAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.14; TCGA CESC -0.338; TCGA COAD -0.379; TCGA ESCA -0.319; TCGA KIRC -0.149; TCGA PAAD -0.167; TCGA PRAD -0.13; TCGA STAD -0.278; TCGA UCEC -0.115 |
hsa-miR-335-5p | RRAD | 9 cancers: BLCA; COAD; KIRC; LUAD; PAAD; PRAD; SARC; THCA; STAD | miRNAWalker2 validate | TCGA BLCA -0.284; TCGA COAD -0.517; TCGA KIRC -0.18; TCGA LUAD -0.295; TCGA PAAD -0.26; TCGA PRAD -0.249; TCGA SARC -0.23; TCGA THCA -0.374; TCGA STAD -0.428 |
hsa-miR-335-5p | RSPO3 | 10 cancers: BLCA; CESC; COAD; ESCA; LUAD; LUSC; PAAD; PRAD; THCA; STAD | miRNAWalker2 validate | TCGA BLCA -0.457; TCGA CESC -0.433; TCGA COAD -1.008; TCGA ESCA -0.802; TCGA LUAD -0.273; TCGA LUSC -0.273; TCGA PAAD -0.651; TCGA PRAD -0.266; TCGA THCA -0.274; TCGA STAD -0.436 |
hsa-miR-335-5p | SDC3 | 10 cancers: BLCA; COAD; HNSC; KIRC; LUAD; PAAD; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.133; TCGA COAD -0.168; TCGA HNSC -0.118; TCGA KIRC -0.084; TCGA LUAD -0.078; TCGA PAAD -0.169; TCGA PRAD -0.177; TCGA THCA -0.209; TCGA STAD -0.176; TCGA UCEC -0.138 |
hsa-miR-335-5p | SEMA4B | 10 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; SARC; THCA | miRNAWalker2 validate | TCGA BLCA -0.099; TCGA BRCA -0.091; TCGA CESC -0.235; TCGA COAD -0.176; TCGA ESCA -0.173; TCGA HNSC -0.248; TCGA LGG -0.141; TCGA LUAD -0.203; TCGA SARC -0.177; TCGA THCA -0.057 |
hsa-miR-335-5p | SERPINB1 | 11 cancers: BLCA; CESC; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PRAD; SARC; THCA | miRNAWalker2 validate | TCGA BLCA -0.244; TCGA CESC -0.172; TCGA HNSC -0.151; TCGA KIRC -0.091; TCGA KIRP -0.064; TCGA LIHC -0.085; TCGA LUAD -0.089; TCGA LUSC -0.135; TCGA PRAD -0.153; TCGA SARC -0.063; TCGA THCA -0.226 |
hsa-miR-335-5p | SERPING1 | 11 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; THCA; STAD | miRNAWalker2 validate | TCGA BLCA -0.326; TCGA CESC -0.173; TCGA COAD -0.639; TCGA ESCA -0.358; TCGA HNSC -0.147; TCGA LUAD -0.115; TCGA LUSC -0.114; TCGA PAAD -0.292; TCGA PRAD -0.178; TCGA THCA -0.243; TCGA STAD -0.176 |
hsa-miR-335-5p | SGCD | 9 cancers: BLCA; COAD; ESCA; LGG; LUAD; LUSC; PAAD; PRAD; STAD | miRNAWalker2 validate; miRNATAP | TCGA BLCA -0.316; TCGA COAD -0.797; TCGA ESCA -0.488; TCGA LGG -0.249; TCGA LUAD -0.251; TCGA LUSC -0.33; TCGA PAAD -0.646; TCGA PRAD -0.178; TCGA STAD -0.471 |
hsa-miR-335-5p | SH3PXD2A | 12 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; THCA; STAD | miRNAWalker2 validate | TCGA BLCA -0.08; TCGA CESC -0.107; TCGA COAD -0.207; TCGA ESCA -0.204; TCGA HNSC -0.056; TCGA KIRC -0.09; TCGA LUAD -0.1; TCGA LUSC -0.199; TCGA PAAD -0.239; TCGA PRAD -0.145; TCGA THCA -0.147; TCGA STAD -0.119 |
hsa-miR-335-5p | SH3PXD2B | 13 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; THCA; STAD | miRNAWalker2 validate | TCGA BLCA -0.104; TCGA CESC -0.144; TCGA COAD -0.199; TCGA ESCA -0.289; TCGA HNSC -0.091; TCGA KIRC -0.111; TCGA KIRP -0.123; TCGA LUAD -0.175; TCGA LUSC -0.21; TCGA PAAD -0.425; TCGA PRAD -0.193; TCGA THCA -0.221; TCGA STAD -0.16 |
hsa-miR-335-5p | SIGLEC8 | 10 cancers: BLCA; BRCA; CESC; COAD; KIRC; KIRP; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.159; TCGA BRCA -0.066; TCGA CESC -0.401; TCGA COAD -0.609; TCGA KIRC -0.759; TCGA KIRP -0.239; TCGA SARC -0.203; TCGA THCA -0.327; TCGA STAD -0.229; TCGA UCEC -0.173 |
hsa-miR-335-5p | SLC6A9 | 9 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LIHC; LUAD; PRAD; SARC | miRNAWalker2 validate | TCGA BLCA -0.165; TCGA BRCA -0.231; TCGA CESC -0.166; TCGA ESCA -0.139; TCGA HNSC -0.131; TCGA LIHC -0.197; TCGA LUAD -0.121; TCGA PRAD -0.059; TCGA SARC -0.114 |
hsa-miR-335-5p | SLFN5 | 12 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | miRNAWalker2 validate | TCGA BLCA -0.164; TCGA CESC -0.109; TCGA COAD -0.45; TCGA ESCA -0.174; TCGA HNSC -0.139; TCGA LUAD -0.117; TCGA LUSC -0.242; TCGA PAAD -0.275; TCGA PRAD -0.226; TCGA SARC -0.107; TCGA THCA -0.306; TCGA STAD -0.169 |
hsa-miR-335-5p | SPIRE1 | 9 cancers: BLCA; COAD; ESCA; KIRC; LGG; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.086; TCGA COAD -0.335; TCGA ESCA -0.317; TCGA KIRC -0.115; TCGA LGG -0.12; TCGA SARC -0.081; TCGA THCA -0.118; TCGA STAD -0.247; TCGA UCEC -0.245 |
hsa-miR-335-5p | SPP1 | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; THCA; UCEC | miRNAWalker2 validate | TCGA BLCA -0.148; TCGA BRCA -0.324; TCGA CESC -0.267; TCGA COAD -1.062; TCGA ESCA -0.356; TCGA HNSC -0.297; TCGA LIHC -0.389; TCGA LUAD -0.474; TCGA LUSC -0.309; TCGA THCA -0.617; TCGA UCEC -0.378 |
hsa-miR-335-5p | SPSB1 | 12 cancers: BLCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.141; TCGA CESC -0.12; TCGA COAD -0.258; TCGA ESCA -0.292; TCGA HNSC -0.059; TCGA LGG -0.081; TCGA LUAD -0.167; TCGA LUSC -0.155; TCGA PAAD -0.348; TCGA THCA -0.143; TCGA STAD -0.125; TCGA UCEC -0.092 |
hsa-miR-335-5p | SSPN | 9 cancers: BLCA; COAD; ESCA; KIRC; LUAD; LUSC; PAAD; PRAD; STAD | miRNAWalker2 validate | TCGA BLCA -0.157; TCGA COAD -0.467; TCGA ESCA -0.376; TCGA KIRC -0.105; TCGA LUAD -0.161; TCGA LUSC -0.284; TCGA PAAD -0.362; TCGA PRAD -0.187; TCGA STAD -0.333 |
hsa-miR-335-5p | SVIL | 9 cancers: BLCA; CESC; COAD; ESCA; PAAD; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.163; TCGA CESC -0.182; TCGA COAD -0.204; TCGA ESCA -0.339; TCGA PAAD -0.275; TCGA PRAD -0.279; TCGA THCA -0.15; TCGA STAD -0.406; TCGA UCEC -0.154 |
hsa-miR-335-5p | TIMP3 | 12 cancers: BLCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.105; TCGA CESC -0.168; TCGA COAD -0.56; TCGA ESCA -0.476; TCGA HNSC -0.14; TCGA LGG -0.138; TCGA LUAD -0.137; TCGA LUSC -0.205; TCGA PAAD -0.363; TCGA PRAD -0.219; TCGA STAD -0.337; TCGA UCEC -0.163 |
hsa-miR-335-5p | TLL1 | 9 cancers: BLCA; COAD; ESCA; HNSC; KIRC; PAAD; PRAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.334; TCGA COAD -0.801; TCGA ESCA -0.543; TCGA HNSC -0.288; TCGA KIRC -0.358; TCGA PAAD -0.249; TCGA PRAD -0.182; TCGA STAD -0.357; TCGA UCEC -0.328 |
hsa-miR-335-5p | TLR1 | 10 cancers: BLCA; CESC; COAD; ESCA; LUSC; PAAD; PRAD; SARC; THCA; STAD | miRNAWalker2 validate | TCGA BLCA -0.292; TCGA CESC -0.152; TCGA COAD -0.58; TCGA ESCA -0.254; TCGA LUSC -0.226; TCGA PAAD -0.157; TCGA PRAD -0.148; TCGA SARC -0.106; TCGA THCA -0.308; TCGA STAD -0.212 |
hsa-miR-335-5p | TLR2 | 13 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUSC; PAAD; PRAD; SARC; THCA; UCEC | miRNAWalker2 validate | TCGA BLCA -0.225; TCGA CESC -0.142; TCGA COAD -0.414; TCGA ESCA -0.284; TCGA HNSC -0.135; TCGA KIRC -0.155; TCGA KIRP -0.09; TCGA LUSC -0.175; TCGA PAAD -0.247; TCGA PRAD -0.172; TCGA SARC -0.078; TCGA THCA -0.419; TCGA UCEC -0.099 |
hsa-miR-335-5p | TLR4 | 9 cancers: BLCA; CESC; ESCA; LGG; PAAD; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.093; TCGA CESC -0.188; TCGA ESCA -0.218; TCGA LGG -0.097; TCGA PAAD -0.301; TCGA PRAD -0.131; TCGA THCA -0.137; TCGA STAD -0.122; TCGA UCEC -0.145 |
hsa-miR-335-5p | TMCC3 | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LUSC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.241; TCGA CESC -0.238; TCGA COAD -0.209; TCGA ESCA -0.234; TCGA HNSC -0.255; TCGA KIRC -0.145; TCGA LUSC -0.155; TCGA THCA -0.301; TCGA STAD -0.152; TCGA UCEC -0.122 |
hsa-miR-335-5p | TMEM140 | 10 cancers: BLCA; COAD; KIRC; KIRP; LUAD; PAAD; PRAD; SARC; THCA; UCEC | miRNAWalker2 validate | TCGA BLCA -0.096; TCGA COAD -0.27; TCGA KIRC -0.228; TCGA KIRP -0.119; TCGA LUAD -0.077; TCGA PAAD -0.084; TCGA PRAD -0.097; TCGA SARC -0.084; TCGA THCA -0.095; TCGA UCEC -0.105 |
hsa-miR-335-5p | TMOD2 | 10 cancers: BLCA; CESC; COAD; HNSC; KIRC; LUAD; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.102; TCGA CESC -0.226; TCGA COAD -0.194; TCGA HNSC -0.104; TCGA KIRC -0.084; TCGA LUAD -0.088; TCGA PRAD -0.186; TCGA THCA -0.091; TCGA STAD -0.274; TCGA UCEC -0.199 |
hsa-miR-335-5p | TNC | 11 cancers: BLCA; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | miRNAWalker2 validate; miRTarBase | TCGA BLCA -0.419; TCGA COAD -1.009; TCGA ESCA -0.778; TCGA HNSC -0.206; TCGA LUAD -0.371; TCGA LUSC -0.357; TCGA PAAD -0.485; TCGA PRAD -0.098; TCGA SARC -0.31; TCGA THCA -0.848; TCGA STAD -0.441 |
hsa-miR-335-5p | TNFRSF9 | 11 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; THCA | miRNAWalker2 validate | TCGA BLCA -0.267; TCGA BRCA -0.314; TCGA CESC -0.243; TCGA COAD -0.667; TCGA HNSC -0.26; TCGA KIRC -0.441; TCGA KIRP -0.158; TCGA LUAD -0.313; TCGA LUSC -0.364; TCGA PAAD -0.368; TCGA THCA -0.896 |
hsa-miR-335-5p | TNFSF9 | 12 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; LIHC; LUAD; PAAD; THCA; UCEC | miRNAWalker2 validate | TCGA BLCA -0.159; TCGA BRCA -0.077; TCGA CESC -0.317; TCGA COAD -0.456; TCGA HNSC -0.264; TCGA KIRC -0.448; TCGA KIRP -0.247; TCGA LIHC -0.243; TCGA LUAD -0.255; TCGA PAAD -0.35; TCGA THCA -0.973; TCGA UCEC -0.211 |
hsa-miR-335-5p | TRANK1 | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PRAD; STAD | miRNAWalker2 validate | TCGA BLCA -0.153; TCGA CESC -0.15; TCGA COAD -0.289; TCGA ESCA -0.114; TCGA HNSC -0.189; TCGA KIRC -0.065; TCGA LUAD -0.135; TCGA LUSC -0.116; TCGA PRAD -0.071; TCGA STAD -0.114 |
hsa-miR-335-5p | TRIM22 | 11 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; PAAD; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.225; TCGA CESC -0.332; TCGA COAD -0.52; TCGA ESCA -0.259; TCGA HNSC -0.174; TCGA KIRC -0.176; TCGA PAAD -0.196; TCGA PRAD -0.191; TCGA THCA -0.577; TCGA STAD -0.197; TCGA UCEC -0.128 |
hsa-miR-335-5p | TRIM69 | 9 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUSC; THCA | miRNAWalker2 validate | TCGA BLCA -0.082; TCGA BRCA -0.066; TCGA CESC -0.185; TCGA COAD -0.408; TCGA ESCA -0.215; TCGA HNSC -0.171; TCGA KIRC -0.209; TCGA LUSC -0.125; TCGA THCA -0.375 |
hsa-miR-335-5p | TTC39B | 11 cancers: BLCA; BRCA; CESC; ESCA; HNSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.162; TCGA BRCA -0.05; TCGA CESC -0.197; TCGA ESCA -0.17; TCGA HNSC -0.126; TCGA PAAD -0.136; TCGA PRAD -0.178; TCGA SARC -0.114; TCGA THCA -0.539; TCGA STAD -0.156; TCGA UCEC -0.106 |
hsa-miR-335-5p | UBD | 9 cancers: BLCA; BRCA; COAD; KIRC; LIHC; LUAD; PAAD; SARC; THCA | miRNAWalker2 validate | TCGA BLCA -0.272; TCGA BRCA -0.125; TCGA COAD -0.303; TCGA KIRC -0.46; TCGA LIHC -0.402; TCGA LUAD -0.203; TCGA PAAD -0.388; TCGA SARC -0.169; TCGA THCA -0.911 |
hsa-miR-335-5p | UGCG | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUSC; PAAD; PRAD; THCA; STAD | miRNAWalker2 validate | TCGA BLCA -0.141; TCGA CESC -0.25; TCGA COAD -0.223; TCGA ESCA -0.141; TCGA HNSC -0.126; TCGA LUSC -0.151; TCGA PAAD -0.19; TCGA PRAD -0.202; TCGA THCA -0.284; TCGA STAD -0.154 |
hsa-miR-335-5p | WISP1 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.186; TCGA BRCA -0.391; TCGA CESC -0.215; TCGA COAD -0.699; TCGA ESCA -0.35; TCGA HNSC -0.286; TCGA LUAD -0.291; TCGA LUSC -0.422; TCGA PAAD -0.764; TCGA PRAD -0.229; TCGA SARC -0.164; TCGA THCA -0.712; TCGA STAD -0.163; TCGA UCEC -0.137 |
hsa-miR-335-5p | WNT9A | 10 cancers: BLCA; BRCA; CESC; COAD; ESCA; LUSC; PAAD; PRAD; THCA; STAD | miRNAWalker2 validate | TCGA BLCA -0.216; TCGA BRCA -0.147; TCGA CESC -0.318; TCGA COAD -0.719; TCGA ESCA -0.729; TCGA LUSC -0.287; TCGA PAAD -0.351; TCGA PRAD -0.231; TCGA THCA -0.174; TCGA STAD -0.58 |
hsa-miR-335-5p | XAF1 | 14 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | miRNAWalker2 validate | TCGA BLCA -0.127; TCGA CESC -0.251; TCGA COAD -0.372; TCGA ESCA -0.155; TCGA HNSC -0.334; TCGA KIRC -0.241; TCGA LIHC -0.1; TCGA LUAD -0.205; TCGA LUSC -0.184; TCGA PAAD -0.177; TCGA PRAD -0.103; TCGA SARC -0.067; TCGA THCA -0.309; TCGA STAD -0.111 |
hsa-miR-335-5p | XIRP1 | 10 cancers: BLCA; BRCA; CESC; COAD; ESCA; LUAD; LUSC; PAAD; PRAD; THCA | miRNAWalker2 validate | TCGA BLCA -0.274; TCGA BRCA -0.312; TCGA CESC -0.238; TCGA COAD -0.782; TCGA ESCA -0.613; TCGA LUAD -0.526; TCGA LUSC -0.388; TCGA PAAD -0.692; TCGA PRAD -0.493; TCGA THCA -0.291 |
hsa-miR-335-5p | ZEB1 | 10 cancers: BLCA; COAD; ESCA; KIRC; LGG; LUSC; PAAD; PRAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.228; TCGA COAD -0.525; TCGA ESCA -0.289; TCGA KIRC -0.092; TCGA LGG -0.11; TCGA LUSC -0.135; TCGA PAAD -0.272; TCGA PRAD -0.233; TCGA STAD -0.412; TCGA UCEC -0.196 |
hsa-miR-335-5p | ZPLD1 | 9 cancers: BLCA; BRCA; ESCA; HNSC; LUAD; LUSC; PAAD; SARC; STAD | miRNAWalker2 validate | TCGA BLCA -0.173; TCGA BRCA -0.188; TCGA ESCA -0.249; TCGA HNSC -0.339; TCGA LUAD -0.451; TCGA LUSC -0.413; TCGA PAAD -0.54; TCGA SARC -0.239; TCGA STAD -0.297 |
hsa-miR-335-5p | SGMS2 | 10 cancers: BLCA; COAD; ESCA; HNSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.213; TCGA COAD -0.344; TCGA ESCA -0.121; TCGA HNSC -0.104; TCGA PAAD -0.39; TCGA PRAD -0.087; TCGA SARC -0.087; TCGA THCA -0.175; TCGA STAD -0.189; TCGA UCEC -0.217 |
hsa-miR-335-5p | ROCK1 | 9 cancers: BLCA; COAD; ESCA; LGG; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.078; TCGA COAD -0.173; TCGA ESCA -0.1; TCGA LGG -0.052; TCGA PRAD -0.11; TCGA SARC -0.086; TCGA THCA -0.114; TCGA STAD -0.119; TCGA UCEC -0.126 |
hsa-miR-335-5p | ADAM19 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.263; TCGA BRCA -0.196; TCGA CESC -0.146; TCGA COAD -0.349; TCGA ESCA -0.253; TCGA HNSC -0.168; TCGA KIRC -0.113; TCGA LUAD -0.195; TCGA LUSC -0.263; TCGA PAAD -0.472; TCGA PRAD -0.226; TCGA SARC -0.128; TCGA THCA -0.461; TCGA STAD -0.192 |
hsa-miR-335-5p | CORO1C | 14 cancers: BLCA; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.164; TCGA COAD -0.097; TCGA ESCA -0.219; TCGA HNSC -0.116; TCGA KIRC -0.107; TCGA KIRP -0.098; TCGA LGG -0.095; TCGA LUAD -0.073; TCGA PAAD -0.296; TCGA PRAD -0.209; TCGA SARC -0.115; TCGA THCA -0.258; TCGA STAD -0.143; TCGA UCEC -0.195 |
hsa-miR-335-5p | PTPN22 | 12 cancers: BLCA; CESC; COAD; HNSC; KIRC; LUAD; LUSC; PAAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.236; TCGA CESC -0.304; TCGA COAD -0.278; TCGA HNSC -0.169; TCGA KIRC -0.291; TCGA LUAD -0.166; TCGA LUSC -0.197; TCGA PAAD -0.305; TCGA SARC -0.216; TCGA THCA -0.77; TCGA STAD -0.136; TCGA UCEC -0.141 |
hsa-miR-335-5p | CALU | 11 cancers: BLCA; BRCA; COAD; HNSC; KIRP; LUAD; LUSC; PAAD; PRAD; THCA; UCEC | MirTarget | TCGA BLCA -0.077; TCGA BRCA -0.08; TCGA COAD -0.158; TCGA HNSC -0.062; TCGA KIRP -0.06; TCGA LUAD -0.107; TCGA LUSC -0.077; TCGA PAAD -0.442; TCGA PRAD -0.106; TCGA THCA -0.106; TCGA UCEC -0.149 |
hsa-miR-335-5p | GBP1 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; UCEC | MirTarget | TCGA BLCA -0.245; TCGA BRCA -0.056; TCGA CESC -0.246; TCGA COAD -0.466; TCGA ESCA -0.175; TCGA HNSC -0.349; TCGA KIRC -0.199; TCGA LUAD -0.16; TCGA LUSC -0.163; TCGA PAAD -0.388; TCGA PRAD -0.165; TCGA SARC -0.238; TCGA THCA -0.183; TCGA UCEC -0.237 |
hsa-miR-335-5p | ZNF532 | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LUSC; PAAD; PRAD; STAD | MirTarget | TCGA BLCA -0.146; TCGA CESC -0.166; TCGA COAD -0.454; TCGA ESCA -0.214; TCGA HNSC -0.057; TCGA KIRC -0.138; TCGA LUSC -0.082; TCGA PAAD -0.29; TCGA PRAD -0.102; TCGA STAD -0.183 |
hsa-miR-335-5p | ZEB2 | 11 cancers: BLCA; CESC; COAD; ESCA; KIRC; LUSC; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.232; TCGA CESC -0.191; TCGA COAD -0.628; TCGA ESCA -0.264; TCGA KIRC -0.064; TCGA LUSC -0.178; TCGA PAAD -0.308; TCGA PRAD -0.252; TCGA THCA -0.144; TCGA STAD -0.249; TCGA UCEC -0.203 |
hsa-miR-335-5p | IFFO1 | 12 cancers: BLCA; CESC; COAD; ESCA; KIRC; LIHC; LUAD; LUSC; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.194; TCGA CESC -0.177; TCGA COAD -0.414; TCGA ESCA -0.223; TCGA KIRC -0.232; TCGA LIHC -0.129; TCGA LUAD -0.184; TCGA LUSC -0.129; TCGA PRAD -0.164; TCGA SARC -0.051; TCGA THCA -0.196; TCGA STAD -0.194 |
hsa-miR-335-5p | FOXN3 | 9 cancers: BLCA; CESC; ESCA; KIRC; LGG; PAAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.103; TCGA CESC -0.086; TCGA ESCA -0.228; TCGA KIRC -0.056; TCGA LGG -0.075; TCGA PAAD -0.169; TCGA THCA -0.122; TCGA STAD -0.214; TCGA UCEC -0.159 |
hsa-miR-335-5p | EIF2AK2 | 10 cancers: BLCA; COAD; HNSC; LUAD; LUSC; PAAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.056; TCGA COAD -0.07; TCGA HNSC -0.207; TCGA LUAD -0.073; TCGA LUSC -0.11; TCGA PAAD -0.18; TCGA SARC -0.05; TCGA THCA -0.136; TCGA STAD -0.073; TCGA UCEC -0.173 |
hsa-miR-335-5p | CD84 | 12 cancers: BLCA; CESC; COAD; HNSC; KIRC; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.268; TCGA CESC -0.379; TCGA COAD -0.816; TCGA HNSC -0.144; TCGA KIRC -0.326; TCGA LUSC -0.261; TCGA PAAD -0.299; TCGA PRAD -0.28; TCGA SARC -0.148; TCGA THCA -0.566; TCGA STAD -0.169; TCGA UCEC -0.169 |
hsa-miR-335-5p | CAMK2A | 10 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LUSC; PAAD; PRAD; SARC; STAD | mirMAP | TCGA BLCA -0.454; TCGA BRCA -0.16; TCGA CESC -0.23; TCGA ESCA -0.612; TCGA HNSC -0.2; TCGA LUSC -0.261; TCGA PAAD -0.356; TCGA PRAD -0.448; TCGA SARC -0.139; TCGA STAD -0.401 |
hsa-miR-335-5p | PTGS1 | 10 cancers: BLCA; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; THCA; STAD | mirMAP | TCGA BLCA -0.592; TCGA COAD -0.504; TCGA ESCA -0.386; TCGA HNSC -0.259; TCGA LUAD -0.191; TCGA LUSC -0.263; TCGA PAAD -0.325; TCGA PRAD -0.374; TCGA THCA -0.293; TCGA STAD -0.229 |
hsa-miR-335-5p | DRP2 | 9 cancers: BLCA; BRCA; ESCA; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.115; TCGA BRCA -0.19; TCGA ESCA -0.262; TCGA LUAD -0.271; TCGA LUSC -0.209; TCGA PAAD -0.481; TCGA PRAD -0.185; TCGA STAD -0.253; TCGA UCEC -0.14 |
hsa-miR-335-5p | MEF2D | 9 cancers: BLCA; COAD; ESCA; KIRC; LIHC; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.105; TCGA COAD -0.101; TCGA ESCA -0.11; TCGA KIRC -0.076; TCGA LIHC -0.093; TCGA PRAD -0.093; TCGA SARC -0.06; TCGA STAD -0.094; TCGA UCEC -0.07 |
hsa-miR-335-5p | RIMS3 | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; LIHC; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.129; TCGA CESC -0.228; TCGA COAD -0.216; TCGA ESCA -0.318; TCGA HNSC -0.318; TCGA LIHC -0.137; TCGA PRAD -0.19; TCGA SARC -0.208; TCGA STAD -0.273; TCGA UCEC -0.212 |
hsa-miR-335-5p | HIVEP3 | 9 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; SARC; UCEC | mirMAP | TCGA BLCA -0.194; TCGA CESC -0.363; TCGA COAD -0.465; TCGA ESCA -0.233; TCGA HNSC -0.113; TCGA LUAD -0.148; TCGA LUSC -0.185; TCGA SARC -0.057; TCGA UCEC -0.153 |
hsa-miR-335-5p | ABL2 | 9 cancers: BLCA; ESCA; HNSC; KIRC; LGG; LUAD; LUSC; PAAD; THCA | mirMAP | TCGA BLCA -0.068; TCGA ESCA -0.173; TCGA HNSC -0.169; TCGA KIRC -0.069; TCGA LGG -0.052; TCGA LUAD -0.062; TCGA LUSC -0.109; TCGA PAAD -0.1; TCGA THCA -0.116 |
hsa-miR-335-5p | LPP | 9 cancers: BLCA; COAD; ESCA; LUSC; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.176; TCGA COAD -0.292; TCGA ESCA -0.206; TCGA LUSC -0.111; TCGA PAAD -0.401; TCGA PRAD -0.352; TCGA SARC -0.257; TCGA STAD -0.443; TCGA UCEC -0.133 |
hsa-miR-335-5p | JPH2 | 12 cancers: BLCA; COAD; ESCA; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.455; TCGA COAD -0.896; TCGA ESCA -0.598; TCGA KIRC -0.208; TCGA KIRP -0.135; TCGA LUAD -0.213; TCGA LUSC -0.189; TCGA PAAD -0.553; TCGA PRAD -0.369; TCGA SARC -0.431; TCGA STAD -0.689; TCGA UCEC -0.188 |
hsa-miR-335-5p | IL6R | 10 cancers: BLCA; COAD; ESCA; KIRC; LUSC; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.269; TCGA COAD -0.315; TCGA ESCA -0.235; TCGA KIRC -0.192; TCGA LUSC -0.11; TCGA PRAD -0.182; TCGA SARC -0.108; TCGA THCA -0.36; TCGA STAD -0.141; TCGA UCEC -0.201 |
hsa-miR-335-5p | KLHL21 | 10 cancers: BLCA; CESC; COAD; ESCA; LIHC; LUSC; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.097; TCGA CESC -0.198; TCGA COAD -0.129; TCGA ESCA -0.212; TCGA LIHC -0.261; TCGA LUSC -0.125; TCGA PRAD -0.105; TCGA SARC -0.147; TCGA STAD -0.137; TCGA UCEC -0.135 |
hsa-miR-335-5p | DUSP7 | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; UCEC | mirMAP | TCGA BLCA -0.139; TCGA CESC -0.274; TCGA COAD -0.111; TCGA ESCA -0.302; TCGA HNSC -0.227; TCGA KIRC -0.1; TCGA LUAD -0.092; TCGA LUSC -0.198; TCGA PAAD -0.118; TCGA UCEC -0.128 |
hsa-miR-335-5p | MAP3K2 | 12 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | mirMAP; miRNATAP | TCGA BLCA -0.082; TCGA CESC -0.105; TCGA COAD -0.066; TCGA ESCA -0.118; TCGA HNSC -0.097; TCGA LUAD -0.07; TCGA LUSC -0.123; TCGA PAAD -0.177; TCGA PRAD -0.151; TCGA SARC -0.064; TCGA STAD -0.096; TCGA UCEC -0.21 |
hsa-miR-335-5p | MCC | 9 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUSC; PRAD; THCA; STAD | mirMAP | TCGA BLCA -0.086; TCGA CESC -0.256; TCGA COAD -0.519; TCGA ESCA -0.519; TCGA HNSC -0.119; TCGA LUSC -0.191; TCGA PRAD -0.168; TCGA THCA -0.141; TCGA STAD -0.297 |
hsa-miR-335-5p | PTRF | 10 cancers: BLCA; COAD; ESCA; HNSC; KIRC; LUAD; PAAD; PRAD; THCA; STAD | mirMAP | TCGA BLCA -0.317; TCGA COAD -0.536; TCGA ESCA -0.473; TCGA HNSC -0.153; TCGA KIRC -0.06; TCGA LUAD -0.102; TCGA PAAD -0.355; TCGA PRAD -0.222; TCGA THCA -0.085; TCGA STAD -0.298 |
hsa-miR-335-5p | HHIPL1 | 10 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD | mirMAP | TCGA BLCA -0.137; TCGA BRCA -0.174; TCGA COAD -0.559; TCGA ESCA -0.223; TCGA HNSC -0.106; TCGA KIRC -0.085; TCGA LUAD -0.383; TCGA LUSC -0.19; TCGA PAAD -0.45; TCGA PRAD -0.166 |
hsa-miR-335-5p | GJC1 | 10 cancers: BLCA; COAD; ESCA; HNSC; KIRC; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.111; TCGA COAD -0.373; TCGA ESCA -0.171; TCGA HNSC -0.181; TCGA KIRC -0.367; TCGA PAAD -0.254; TCGA PRAD -0.285; TCGA SARC -0.062; TCGA STAD -0.316; TCGA UCEC -0.138 |
hsa-miR-335-5p | TEAD1 | 9 cancers: BLCA; ESCA; LUAD; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP; miRNATAP | TCGA BLCA -0.094; TCGA ESCA -0.117; TCGA LUAD -0.07; TCGA PAAD -0.232; TCGA PRAD -0.16; TCGA SARC -0.055; TCGA THCA -0.129; TCGA STAD -0.213; TCGA UCEC -0.144 |
hsa-miR-335-5p | AFAP1 | 11 cancers: BLCA; COAD; ESCA; LGG; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.16; TCGA COAD -0.086; TCGA ESCA -0.13; TCGA LGG -0.061; TCGA LUAD -0.138; TCGA LUSC -0.149; TCGA PAAD -0.279; TCGA PRAD -0.121; TCGA THCA -0.084; TCGA STAD -0.185; TCGA UCEC -0.113 |
hsa-miR-335-5p | MYO1C | 9 cancers: BLCA; COAD; ESCA; HNSC; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.088; TCGA COAD -0.153; TCGA ESCA -0.167; TCGA HNSC -0.076; TCGA PAAD -0.139; TCGA PRAD -0.104; TCGA SARC -0.062; TCGA THCA -0.118; TCGA STAD -0.128 |
hsa-miR-335-5p | NFAM1 | 9 cancers: BLCA; BRCA; CESC; COAD; KIRC; LUAD; PAAD; THCA; UCEC | mirMAP | TCGA BLCA -0.175; TCGA BRCA -0.122; TCGA CESC -0.187; TCGA COAD -0.441; TCGA KIRC -0.24; TCGA LUAD -0.127; TCGA PAAD -0.164; TCGA THCA -0.264; TCGA UCEC -0.146 |
hsa-miR-335-5p | PLEKHO2 | 9 cancers: BLCA; CESC; COAD; ESCA; KIRC; LUSC; PAAD; PRAD; STAD | mirMAP | TCGA BLCA -0.15; TCGA CESC -0.094; TCGA COAD -0.427; TCGA ESCA -0.2; TCGA KIRC -0.108; TCGA LUSC -0.077; TCGA PAAD -0.185; TCGA PRAD -0.121; TCGA STAD -0.13 |
hsa-miR-335-5p | FMN1 | 9 cancers: BLCA; CESC; COAD; HNSC; LUAD; PAAD; PRAD; SARC; STAD | miRNATAP | TCGA BLCA -0.301; TCGA CESC -0.205; TCGA COAD -0.168; TCGA HNSC -0.142; TCGA LUAD -0.141; TCGA PAAD -0.286; TCGA PRAD -0.217; TCGA SARC -0.24; TCGA STAD -0.094 |
hsa-miR-335-5p | CNN1 | 9 cancers: BLCA; COAD; ESCA; LUAD; LUSC; PAAD; PRAD; SARC; STAD | miRNATAP | TCGA BLCA -0.541; TCGA COAD -1.052; TCGA ESCA -0.746; TCGA LUAD -0.172; TCGA LUSC -0.181; TCGA PAAD -0.659; TCGA PRAD -0.348; TCGA SARC -0.385; TCGA STAD -0.783 |
hsa-miR-335-5p | COL5A2 | 12 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; THCA; UCEC | miRNATAP | TCGA BLCA -0.177; TCGA BRCA -0.19; TCGA COAD -0.695; TCGA ESCA -0.312; TCGA HNSC -0.384; TCGA KIRC -0.151; TCGA LUAD -0.441; TCGA LUSC -0.448; TCGA PAAD -0.76; TCGA PRAD -0.097; TCGA THCA -0.414; TCGA UCEC -0.158 |
hsa-miR-335-5p | MBNL1 | 11 cancers: BLCA; CESC; COAD; ESCA; KIRC; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.133; TCGA CESC -0.076; TCGA COAD -0.067; TCGA ESCA -0.171; TCGA KIRC -0.081; TCGA PAAD -0.132; TCGA PRAD -0.09; TCGA SARC -0.151; TCGA THCA -0.117; TCGA STAD -0.241; TCGA UCEC -0.125 |
hsa-miR-335-5p | FGF2 | 9 cancers: BLCA; COAD; ESCA; LGG; PAAD; PRAD; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.204; TCGA COAD -0.537; TCGA ESCA -0.323; TCGA LGG -0.14; TCGA PAAD -0.378; TCGA PRAD -0.228; TCGA THCA -0.3; TCGA STAD -0.377; TCGA UCEC -0.151 |
hsa-miR-335-5p | LSM11 | 9 cancers: BLCA; CESC; ESCA; LUSC; PAAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.111; TCGA CESC -0.052; TCGA ESCA -0.115; TCGA LUSC -0.058; TCGA PAAD -0.154; TCGA PRAD -0.11; TCGA SARC -0.067; TCGA STAD -0.143; TCGA UCEC -0.081 |
hsa-miR-335-5p | HCFC2 | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; LGG; LUSC; PRAD; STAD; UCEC | miRNATAP | TCGA BLCA -0.113; TCGA CESC -0.127; TCGA COAD -0.229; TCGA ESCA -0.207; TCGA HNSC -0.078; TCGA LGG -0.054; TCGA LUSC -0.057; TCGA PRAD -0.14; TCGA STAD -0.25; TCGA UCEC -0.117 |
hsa-miR-335-5p | ABCA12 | 9 cancers: BRCA; CESC; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; THCA | miRNAWalker2 validate | TCGA BRCA -0.173; TCGA CESC -0.597; TCGA HNSC -0.445; TCGA KIRC -0.364; TCGA KIRP -0.245; TCGA LUAD -0.64; TCGA LUSC -0.464; TCGA PAAD -0.655; TCGA THCA -0.993 |
hsa-miR-335-5p | CD276 | 9 cancers: BRCA; COAD; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; THCA | miRNAWalker2 validate | TCGA BRCA -0.125; TCGA COAD -0.183; TCGA HNSC -0.185; TCGA KIRC -0.08; TCGA KIRP -0.073; TCGA LUAD -0.147; TCGA LUSC -0.096; TCGA PAAD -0.317; TCGA THCA -0.219 |
hsa-miR-335-5p | CDCP1 | 10 cancers: BRCA; CESC; COAD; HNSC; LUAD; LUSC; PAAD; PRAD; SARC; THCA | miRNAWalker2 validate | TCGA BRCA -0.206; TCGA CESC -0.101; TCGA COAD -0.087; TCGA HNSC -0.229; TCGA LUAD -0.245; TCGA LUSC -0.215; TCGA PAAD -0.245; TCGA PRAD -0.082; TCGA SARC -0.226; TCGA THCA -0.231 |
hsa-miR-335-5p | COL10A1 | 10 cancers: BRCA; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; SARC; THCA; UCEC | miRNAWalker2 validate | TCGA BRCA -0.758; TCGA COAD -1.252; TCGA ESCA -0.438; TCGA HNSC -0.442; TCGA LUAD -0.586; TCGA LUSC -0.617; TCGA PAAD -0.911; TCGA SARC -0.228; TCGA THCA -1.048; TCGA UCEC -0.286 |
hsa-miR-335-5p | DLX5 | 9 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; PAAD; THCA | miRNAWalker2 validate | TCGA BRCA -0.272; TCGA CESC -0.27; TCGA COAD -0.416; TCGA ESCA -0.46; TCGA HNSC -0.168; TCGA KIRC -0.502; TCGA LUAD -0.28; TCGA PAAD -0.296; TCGA THCA -0.243 |
hsa-miR-335-5p | GJB5 | 9 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD | miRNAWalker2 validate | TCGA BRCA -0.251; TCGA CESC -0.489; TCGA COAD -0.866; TCGA ESCA -0.435; TCGA HNSC -0.195; TCGA KIRP -0.213; TCGA LUAD -0.298; TCGA LUSC -0.489; TCGA PAAD -0.621 |
hsa-miR-335-5p | KLHDC7B | 9 cancers: BRCA; CESC; COAD; ESCA; LIHC; LUAD; LUSC; PAAD; THCA | miRNAWalker2 validate | TCGA BRCA -0.233; TCGA CESC -0.434; TCGA COAD -0.442; TCGA ESCA -0.365; TCGA LIHC -0.171; TCGA LUAD -0.3; TCGA LUSC -0.346; TCGA PAAD -0.37; TCGA THCA -0.788 |
hsa-miR-335-5p | MYO9B | 13 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; LIHC; LUAD; LUSC; PAAD; SARC; THCA; STAD | miRNAWalker2 validate | TCGA BRCA -0.079; TCGA CESC -0.071; TCGA COAD -0.142; TCGA ESCA -0.109; TCGA HNSC -0.061; TCGA KIRC -0.136; TCGA LIHC -0.088; TCGA LUAD -0.118; TCGA LUSC -0.057; TCGA PAAD -0.125; TCGA SARC -0.061; TCGA THCA -0.119; TCGA STAD -0.075 |
hsa-miR-335-5p | OAS1 | 9 cancers: BRCA; CESC; HNSC; KIRC; KIRP; LUAD; SARC; THCA; UCEC | miRNAWalker2 validate | TCGA BRCA -0.111; TCGA CESC -0.25; TCGA HNSC -0.214; TCGA KIRC -0.194; TCGA KIRP -0.087; TCGA LUAD -0.214; TCGA SARC -0.095; TCGA THCA -0.421; TCGA UCEC -0.21 |
hsa-miR-335-5p | OAS2 | 11 cancers: BRCA; CESC; COAD; HNSC; KIRC; LUAD; LUSC; PAAD; SARC; THCA; UCEC | miRNAWalker2 validate | TCGA BRCA -0.12; TCGA CESC -0.293; TCGA COAD -0.588; TCGA HNSC -0.336; TCGA KIRC -0.135; TCGA LUAD -0.195; TCGA LUSC -0.188; TCGA PAAD -0.262; TCGA SARC -0.12; TCGA THCA -0.307; TCGA UCEC -0.157 |
hsa-miR-335-5p | P4HA1 | 11 cancers: BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; PAAD; THCA; UCEC | miRNAWalker2 validate | TCGA BRCA -0.116; TCGA COAD -0.174; TCGA ESCA -0.099; TCGA HNSC -0.095; TCGA KIRC -0.219; TCGA KIRP -0.091; TCGA LGG -0.122; TCGA LUAD -0.089; TCGA PAAD -0.257; TCGA THCA -0.059; TCGA UCEC -0.157 |
hsa-miR-335-5p | RHBDF2 | 11 cancers: BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; THCA | miRNAWalker2 validate | TCGA BRCA -0.128; TCGA CESC -0.178; TCGA ESCA -0.098; TCGA HNSC -0.188; TCGA KIRC -0.242; TCGA KIRP -0.124; TCGA LIHC -0.075; TCGA LUAD -0.233; TCGA LUSC -0.127; TCGA PAAD -0.204; TCGA THCA -0.166 |
hsa-miR-335-5p | RUNX2 | 10 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; THCA | miRNAWalker2 validate; miRTarBase | TCGA BRCA -0.17; TCGA CESC -0.21; TCGA COAD -0.274; TCGA ESCA -0.146; TCGA HNSC -0.111; TCGA KIRC -0.098; TCGA LUAD -0.142; TCGA LUSC -0.233; TCGA PAAD -0.488; TCGA THCA -0.544 |
hsa-miR-335-5p | SEC24D | 9 cancers: BRCA; COAD; KIRC; LUAD; LUSC; PAAD; PRAD; THCA; UCEC | miRNAWalker2 validate | TCGA BRCA -0.069; TCGA COAD -0.251; TCGA KIRC -0.074; TCGA LUAD -0.122; TCGA LUSC -0.115; TCGA PAAD -0.192; TCGA PRAD -0.133; TCGA THCA -0.09; TCGA UCEC -0.1 |
hsa-miR-335-5p | SLC37A2 | 9 cancers: BRCA; CESC; COAD; ESCA; KIRC; LUAD; LUSC; PAAD; THCA | miRNAWalker2 validate | TCGA BRCA -0.091; TCGA CESC -0.364; TCGA COAD -0.654; TCGA ESCA -0.354; TCGA KIRC -0.35; TCGA LUAD -0.122; TCGA LUSC -0.161; TCGA PAAD -0.244; TCGA THCA -0.422 |
hsa-miR-335-5p | UNC13D | 9 cancers: BRCA; CESC; COAD; KIRC; LGG; LUAD; PAAD; SARC; THCA | miRNAWalker2 validate | TCGA BRCA -0.169; TCGA CESC -0.145; TCGA COAD -0.343; TCGA KIRC -0.296; TCGA LGG -0.103; TCGA LUAD -0.223; TCGA PAAD -0.234; TCGA SARC -0.154; TCGA THCA -0.429 |
hsa-miR-335-5p | ADAMDEC1 | 9 cancers: BRCA; CESC; COAD; KIRC; LUAD; LUSC; PAAD; SARC; THCA | MirTarget | TCGA BRCA -0.389; TCGA CESC -0.412; TCGA COAD -0.467; TCGA KIRC -0.559; TCGA LUAD -0.224; TCGA LUSC -0.37; TCGA PAAD -0.457; TCGA SARC -0.307; TCGA THCA -0.817 |
hsa-miR-335-5p | TP73 | 10 cancers: BRCA; CESC; COAD; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; THCA | mirMAP | TCGA BRCA -0.109; TCGA CESC -0.293; TCGA COAD -0.263; TCGA KIRC -0.308; TCGA KIRP -0.169; TCGA LIHC -0.495; TCGA LUAD -0.237; TCGA LUSC -0.191; TCGA PAAD -0.259; TCGA THCA -0.165 |
hsa-miR-335-5p | UNC5B | 11 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; THCA | mirMAP | TCGA BRCA -0.26; TCGA CESC -0.307; TCGA COAD -0.452; TCGA ESCA -0.253; TCGA HNSC -0.085; TCGA KIRC -0.277; TCGA LUAD -0.211; TCGA LUSC -0.285; TCGA PAAD -0.258; TCGA PRAD -0.212; TCGA THCA -0.221 |
hsa-miR-335-5p | SLC36A1 | 13 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; THCA; UCEC | mirMAP | TCGA BRCA -0.052; TCGA CESC -0.086; TCGA COAD -0.104; TCGA ESCA -0.144; TCGA HNSC -0.084; TCGA KIRC -0.123; TCGA KIRP -0.067; TCGA LIHC -0.076; TCGA LUAD -0.131; TCGA LUSC -0.119; TCGA PAAD -0.267; TCGA THCA -0.165; TCGA UCEC -0.086 |
hsa-miR-335-5p | AMPD3 | 10 cancers: CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; SARC; THCA; STAD | miRNAWalker2 validate | TCGA CESC -0.191; TCGA COAD -0.127; TCGA ESCA -0.181; TCGA HNSC -0.111; TCGA KIRP -0.079; TCGA LUAD -0.161; TCGA LUSC -0.17; TCGA SARC -0.098; TCGA THCA -0.108; TCGA STAD -0.088 |
hsa-miR-335-5p | ANO1 | 10 cancers: CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; STAD | miRNAWalker2 validate | TCGA CESC -0.267; TCGA COAD -0.613; TCGA ESCA -0.232; TCGA HNSC -0.329; TCGA KIRC -0.239; TCGA LUAD -0.176; TCGA LUSC -0.418; TCGA PAAD -0.261; TCGA PRAD -0.257; TCGA STAD -0.192 |
hsa-miR-335-5p | BCL6 | 10 cancers: CESC; COAD; ESCA; KIRC; KIRP; LGG; PAAD; PRAD; SARC; STAD | miRNAWalker2 validate | TCGA CESC -0.185; TCGA COAD -0.322; TCGA ESCA -0.337; TCGA KIRC -0.11; TCGA KIRP -0.108; TCGA LGG -0.106; TCGA PAAD -0.195; TCGA PRAD -0.09; TCGA SARC -0.114; TCGA STAD -0.212 |
hsa-miR-335-5p | BHLHE22 | 9 cancers: CESC; COAD; ESCA; LUAD; LUSC; PRAD; SARC; THCA; STAD | miRNAWalker2 validate | TCGA CESC -0.441; TCGA COAD -0.507; TCGA ESCA -0.338; TCGA LUAD -0.165; TCGA LUSC -0.196; TCGA PRAD -0.193; TCGA SARC -0.203; TCGA THCA -0.262; TCGA STAD -0.334 |
hsa-miR-335-5p | CDK17 | 9 cancers: CESC; COAD; ESCA; HNSC; KIRC; PAAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA CESC -0.07; TCGA COAD -0.094; TCGA ESCA -0.19; TCGA HNSC -0.067; TCGA KIRC -0.098; TCGA PAAD -0.117; TCGA THCA -0.077; TCGA STAD -0.156; TCGA UCEC -0.145 |
hsa-miR-335-5p | CYP27C1 | 10 cancers: CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; STAD | miRNAWalker2 validate | TCGA CESC -0.597; TCGA COAD -0.662; TCGA ESCA -0.804; TCGA HNSC -0.463; TCGA LGG -0.19; TCGA LUAD -0.276; TCGA LUSC -0.409; TCGA PAAD -0.413; TCGA PRAD -0.142; TCGA STAD -0.379 |
hsa-miR-335-5p | DNAJC13 | 11 cancers: CESC; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA CESC -0.113; TCGA ESCA -0.077; TCGA HNSC -0.059; TCGA KIRP -0.065; TCGA LUAD -0.061; TCGA LUSC -0.072; TCGA PAAD -0.161; TCGA PRAD -0.125; TCGA SARC -0.054; TCGA STAD -0.13; TCGA UCEC -0.182 |
hsa-miR-335-5p | DOCK9 | 9 cancers: CESC; ESCA; KIRC; LUSC; PAAD; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA CESC -0.219; TCGA ESCA -0.122; TCGA KIRC -0.086; TCGA LUSC -0.084; TCGA PAAD -0.152; TCGA PRAD -0.132; TCGA THCA -0.206; TCGA STAD -0.102; TCGA UCEC -0.103 |
hsa-miR-335-5p | EDEM1 | 9 cancers: CESC; COAD; ESCA; HNSC; LUSC; PAAD; THCA; STAD; UCEC | miRNAWalker2 validate; mirMAP | TCGA CESC -0.095; TCGA COAD -0.132; TCGA ESCA -0.089; TCGA HNSC -0.075; TCGA LUSC -0.09; TCGA PAAD -0.137; TCGA THCA -0.215; TCGA STAD -0.093; TCGA UCEC -0.234 |
hsa-miR-335-5p | EPHA4 | 9 cancers: CESC; COAD; ESCA; HNSC; LUSC; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate; miRNATAP | TCGA CESC -0.261; TCGA COAD -0.615; TCGA ESCA -0.346; TCGA HNSC -0.128; TCGA LUSC -0.126; TCGA PRAD -0.153; TCGA THCA -0.344; TCGA STAD -0.255; TCGA UCEC -0.18 |
hsa-miR-335-5p | FAM63B | 9 cancers: CESC; COAD; ESCA; HNSC; PAAD; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA CESC -0.151; TCGA COAD -0.4; TCGA ESCA -0.194; TCGA HNSC -0.139; TCGA PAAD -0.275; TCGA PRAD -0.23; TCGA SARC -0.1; TCGA STAD -0.22; TCGA UCEC -0.189 |
hsa-miR-335-5p | GCNT4 | 9 cancers: CESC; COAD; ESCA; HNSC; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA CESC -0.292; TCGA COAD -0.549; TCGA ESCA -0.381; TCGA HNSC -0.173; TCGA PRAD -0.43; TCGA SARC -0.196; TCGA THCA -0.252; TCGA STAD -0.346; TCGA UCEC -0.25 |
hsa-miR-335-5p | NOTCH3 | 9 cancers: CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; THCA | miRNAWalker2 validate | TCGA CESC -0.296; TCGA COAD -0.458; TCGA ESCA -0.266; TCGA HNSC -0.102; TCGA KIRC -0.144; TCGA LUAD -0.141; TCGA LUSC -0.193; TCGA PAAD -0.227; TCGA THCA -0.127 |
hsa-miR-335-5p | PTPRE | 9 cancers: CESC; COAD; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; THCA | miRNAWalker2 validate | TCGA CESC -0.126; TCGA COAD -0.075; TCGA HNSC -0.132; TCGA KIRC -0.235; TCGA KIRP -0.08; TCGA LUAD -0.11; TCGA LUSC -0.108; TCGA PAAD -0.147; TCGA THCA -0.589 |
hsa-miR-335-5p | RNF213 | 11 cancers: CESC; COAD; HNSC; KIRC; KIRP; LIHC; LUAD; PAAD; SARC; THCA; UCEC | miRNAWalker2 validate | TCGA CESC -0.169; TCGA COAD -0.175; TCGA HNSC -0.146; TCGA KIRC -0.067; TCGA KIRP -0.071; TCGA LIHC -0.156; TCGA LUAD -0.185; TCGA PAAD -0.114; TCGA SARC -0.07; TCGA THCA -0.18; TCGA UCEC -0.148 |
hsa-miR-335-5p | SPAG9 | 9 cancers: CESC; ESCA; HNSC; KIRC; LGG; PAAD; PRAD; STAD; UCEC | miRNAWalker2 validate | TCGA CESC -0.079; TCGA ESCA -0.148; TCGA HNSC -0.076; TCGA KIRC -0.074; TCGA LGG -0.052; TCGA PAAD -0.082; TCGA PRAD -0.073; TCGA STAD -0.077; TCGA UCEC -0.116 |
hsa-miR-335-5p | STAT2 | 10 cancers: CESC; COAD; ESCA; HNSC; KIRC; LIHC; LUAD; PAAD; THCA; STAD | miRNAWalker2 validate | TCGA CESC -0.101; TCGA COAD -0.263; TCGA ESCA -0.09; TCGA HNSC -0.191; TCGA KIRC -0.078; TCGA LIHC -0.082; TCGA LUAD -0.132; TCGA PAAD -0.121; TCGA THCA -0.171; TCGA STAD -0.093 |
hsa-miR-335-5p | TP53INP1 | 9 cancers: CESC; COAD; ESCA; KIRC; KIRP; LGG; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA CESC -0.17; TCGA COAD -0.181; TCGA ESCA -0.108; TCGA KIRC -0.135; TCGA KIRP -0.086; TCGA LGG -0.102; TCGA THCA -0.179; TCGA STAD -0.187; TCGA UCEC -0.122 |
hsa-miR-335-5p | XRN1 | 10 cancers: CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | miRNAWalker2 validate | TCGA CESC -0.194; TCGA COAD -0.079; TCGA ESCA -0.068; TCGA HNSC -0.091; TCGA LUAD -0.054; TCGA LUSC -0.081; TCGA PAAD -0.087; TCGA PRAD -0.055; TCGA STAD -0.124; TCGA UCEC -0.166 |
hsa-miR-335-5p | KPNA6 | 9 cancers: CESC; ESCA; HNSC; LUSC; PAAD; PRAD; SARC; STAD; UCEC | MirTarget | TCGA CESC -0.063; TCGA ESCA -0.093; TCGA HNSC -0.054; TCGA LUSC -0.05; TCGA PAAD -0.068; TCGA PRAD -0.083; TCGA SARC -0.055; TCGA STAD -0.089; TCGA UCEC -0.116 |
hsa-miR-335-5p | MICALL1 | 10 cancers: CESC; COAD; ESCA; HNSC; LUAD; LUSC; PRAD; SARC; STAD; UCEC | mirMAP | TCGA CESC -0.246; TCGA COAD -0.077; TCGA ESCA -0.34; TCGA HNSC -0.195; TCGA LUAD -0.065; TCGA LUSC -0.104; TCGA PRAD -0.157; TCGA SARC -0.132; TCGA STAD -0.107; TCGA UCEC -0.057 |
hsa-miR-335-5p | TBC1D2B | 12 cancers: CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA CESC -0.117; TCGA COAD -0.153; TCGA ESCA -0.097; TCGA HNSC -0.129; TCGA KIRC -0.111; TCGA LUAD -0.072; TCGA LUSC -0.081; TCGA PAAD -0.179; TCGA PRAD -0.082; TCGA THCA -0.083; TCGA STAD -0.121; TCGA UCEC -0.099 |
hsa-miR-335-5p | HOXD8 | 9 cancers: CESC; COAD; ESCA; HNSC; LIHC; PAAD; PRAD; THCA; UCEC | miRNATAP | TCGA CESC -0.143; TCGA COAD -0.282; TCGA ESCA -0.216; TCGA HNSC -0.193; TCGA LIHC -0.379; TCGA PAAD -0.159; TCGA PRAD -0.163; TCGA THCA -0.187; TCGA UCEC -0.299 |
hsa-miR-335-5p | FKBP14 | 10 cancers: COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA COAD -0.185; TCGA ESCA -0.216; TCGA HNSC -0.158; TCGA LUAD -0.088; TCGA LUSC -0.137; TCGA PAAD -0.352; TCGA PRAD -0.134; TCGA THCA -0.111; TCGA STAD -0.108; TCGA UCEC -0.172 |
hsa-miR-335-5p | FNDC3B | 9 cancers: COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; UCEC | miRNAWalker2 validate | TCGA COAD -0.081; TCGA ESCA -0.092; TCGA HNSC -0.101; TCGA KIRC -0.061; TCGA LUAD -0.178; TCGA LUSC -0.153; TCGA PAAD -0.332; TCGA PRAD -0.131; TCGA UCEC -0.115 |
hsa-miR-335-5p | FUT11 | 9 cancers: COAD; ESCA; HNSC; KIRC; LUSC; PAAD; PRAD; STAD; UCEC | miRNAWalker2 validate | TCGA COAD -0.377; TCGA ESCA -0.135; TCGA HNSC -0.087; TCGA KIRC -0.2; TCGA LUSC -0.074; TCGA PAAD -0.145; TCGA PRAD -0.141; TCGA STAD -0.2; TCGA UCEC -0.096 |
hsa-miR-335-5p | PLEKHF1 | 9 cancers: COAD; ESCA; HNSC; KIRC; LIHC; LUAD; LUSC; PAAD; THCA | miRNAWalker2 validate | TCGA COAD -0.203; TCGA ESCA -0.258; TCGA HNSC -0.085; TCGA KIRC -0.12; TCGA LIHC -0.205; TCGA LUAD -0.107; TCGA LUSC -0.152; TCGA PAAD -0.221; TCGA THCA -0.285 |
hsa-miR-335-5p | TRIM9 | 10 cancers: COAD; ESCA; KIRC; KIRP; LGG; LUSC; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA COAD -0.403; TCGA ESCA -0.527; TCGA KIRC -0.324; TCGA KIRP -0.171; TCGA LGG -0.053; TCGA LUSC -0.184; TCGA PRAD -0.373; TCGA SARC -0.11; TCGA STAD -0.302; TCGA UCEC -0.286 |
Enriched cancer pathways of putative targets